nicotine has been researched along with Alzheimer Disease in 155 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (8.39) | 18.7374 |
| 1990's | 43 (27.74) | 18.2507 |
| 2000's | 59 (38.06) | 29.6817 |
| 2010's | 37 (23.87) | 24.3611 |
| 2020's | 3 (1.94) | 2.80 |
| Authors | Studies |
|---|---|
| Adam, BL; Gao, J; Terry, AV | 1 |
| Chen, GJ; Deng, XJ; Long, Y; Sun, F; Xu, DM; Yan, Z; Yang, J; Zhu, BL | 1 |
| Chen, MF; Chen, PY; Lee, TJF; Shih, CC | 1 |
| Abbasnezhad, A; Abd El-Ghafar, OA; Abhilash, L; Abouzid, KAM; Achberger, AM; Ackerman, S; Akhatayeva, Z; Akin, D; Al-Kaysi, RO; Alakhdar, AA; Alame, M; Aleksic Sabo, V; Alinezhadbalalami, N; Allen, JD; Alonso, JM; Alqatani, S; Alsayed, B; Álvarez Larraondo, M; Alvarez, M; Amini, SB; An, Z; Anasir, MI; Anderson, GH; Andremont, A; Andrés, S; Angel, S; Anigboro, AA; Anini, Y; Antonides, CFJ; Arafa, K; Arafa, RK; Aryal, UK; Asbaghi, O; Assefa, MK; Atyah, M; Avwioroko, OJ; Ayora-Talavera, G; Azpilikueta, A; Azyazov, VN; Ba, YF; Bachmann, KF; Badoual, J; Bae, SJ; Baek, SH; Bahrami, B; Bai, J; Baid-Agrawal, S; Bailey, MR; Baillie, JK; Balani, N; Balcar, VJ; Banica, T; Banks, L; Barb, J; Bardeen, CJ; Barrett, HE; Bartnikowski, N; Bashir, R; Battaglia, M; Bautista-Hernández, V; Becker, B; Beekman, FJ; Benidir, M; Benjelloun, M; Bentley, RF; Bergé, J; Berger, D; Bernsen, MR; Berraondo, P; Bhattacharya, R; Bhayani, SB; Bi, W; Bi, X; Bi, YL; Bi, Z; Bian, K; Biesecker, LG; Billadeau, DD; Blaszczyk, R; Blum, JL; Boachie, R; Boelte, K; Bogers, AJJC; Boileau, I; Bonduelle, C; Bonny, O; Bonsu, JM; Boos, LA; Borges-Argáez, R; Bouchard, PA; Boudot, C; Bourgeade-Delmas, S; Boutet-Robinet, E; Boyle, AJ; Branigan, D; Briones, S; Broniowska, KA; Brossas, JY; Brown, WA; Brzezinska, J; Buitron, G; Burnier, M; Bursulaya, B; Burton, PR; Bush, AA; Busuttil, RW; Cabello-Aguilar, S; Cáceres-Farfán, M; Cacheux, V; Caffrey, PJ; Cai, B; Cai, Q; Cai, S; Cai, Y; Calders, P; Cammarota, G; Campbell, DA; Cancelli, C; Cao, Q; Cao, WH; Cao, X; Capet, M; Capoluongo, E; Carey, ME; Carnero, M; Carrasco, LI; Carreno, J; Carrillo-Reyes, J; Casini, I; Cassar, M; Catalan, G; Cattamanchi, A; Cazares-Granillo, M; Celie, B; Cen, YK; Cena, H; Cerbo, RM; Ceron, E; Cetina-Montejo, L; Chaâbane-Banaoues, R; Chabanet, C; Chace-Donahue, F; Chalfun-Júnior, A; Chan-Balan, R; Chang, CS; Chen, CS; Chen, D; Chen, J; Chen, L; Chen, PN; Chen, Q; Chen, S; Chen, W; Chen, WP; Chen, X; Chen, Z; Cheng, H; Cheng, J; Cheng, Q; Cheng, T; Chi, T; Chianelli, D; Chieppa, M; Child, CJ; Cho, JH; Cho, JY; Chogtu, B; Choi, GH; Choi, J; Choi, M; Choi, NG; Cholu, CO; Chow, ES; Chowdhury, AH; Chu, PC; Chu, Q; Chu, S; Chua, H; Chung, T; Chunyan, L; Church, JS; Civardi, E; Cobiella, J; Colinge, J; Collado, CJ; Collins, TJ; Cong, LM; Conkrite, KL; Cope, SJ; Corbett, JA; Cornet, M; Cornillot, E; Corvaisier, S; Costes-Martineau, V; Courtioux, B; Coussens, M; Covino, M; Criado, A; Cui, J; Cui, Y; Cunitz, BW; Curry, AE; Cussó, L; D'Urzo, AD; D'Urzo, KA; Dabbous, S; Dahlgren, RA; Dai, H; Dai, T; Dai, W; Dalinghaus, M; Dang, S; Davalos, RV; Davidson, H; de Andrea, CE; De Angelis, M; de Blois, E; de Carvalho, PA; De Clercq, E; De Giuseppe, R; de Jong, M; De Langhe, S; De Oliveira, L; de Souza Pinto Lemgruber, R; de Souza, LB; de Swart, J; De Wandele, I; de Woestijne, PCV; Delaney, S; Delorme, M; Delvenne, P; Deng, L; Deng, Z; Denkinger, CM; der Meulen, MHV; Deraeve, C; Desco, M; DeSilva, S; Destere, A; Dhali, A; Di Ciano, P; Dias-Santagata, D; Diskin, SJ; Djè, MK; Doddipatla, S; Doerr, AJ; Dokla, EME; Domiciano, D; Domingo, N; Dong, C; Dong, J; Dong, Q; Dong, S; Dong, X; Dong, Z; Douair, I; Douglas, TA; Doyle, SM; Drain, PK; Du, K; Du, L; Du, Q; Du, S; Duan, C; Duan, H; Duan, J; Duan, S; Duan, W; Dueluzeau, R; Dukic, L; Dunmire, BL; Duvauchelle, T; Dymek, B; Dzwonek, K; Earnest, A; Eckardt, KU; El Ghadraoui, L; El Massoudi, S; Elloumi, F; Elnour, IE; Embarak, S; Ende, M; England, K; Enikeev, D; Enyedy, I; Epple, R; Erickson, GE; Eriksson, J; Erndt-Marino, J; Errachidi, F; Etxeberria, I; Evan, AP; Fairlamb, AH; Falahi, E; Fan, CC; Fan, H; Fan, M; Fan, MZ; Fan, S; Fan, Y; Fang, CS; Fang, J; Fang, X; Fang, Z; Farmany, A; Farooqi, A; Farouk, HO; Fazelipour, S; Feng, D; Feng, J; Feng, JX; Feng, YL; Ferraz, SL; Ferreira, CR; Figenshau, RS; Finn, AV; Fiseha, T; Fleischer, AS; Fogleman, AD; Fontaine, O; Ford, CR; Fouladvand, F; Four, M; Fousteri, G; Francis, JR; Fraser, JF; Frazier, RP; Fu, H; Fu, P; Fu, YJ; Fujishima, A; Fuster, V; Gabilan, JC; Gagliani, N; Gai, QY; Galán-Arriola, C; Gale, P; Galimova, GR; Galkin, A; Gallo, A; Gallo, AA; Gang, DD; Ganschow, S; Gao, C; Gao, F; Gao, GP; Gao, H; Gao, K; Gao, M; Gao, MY; Gao, P; Gao, R; Gao, S; Gao, WJ; Gao, Y; Garbacz, P; García Ruiz, L; Garcia, EM; Garofoli, F; Gasbarrini, A; Gattinoni, L; Gaudig, M; Gbureck, U; Ge, X; Genko, N; Gentile, GL; George, MW; Gerety, GF; Gestwicki, JE; Geusens, PP; Ghassemi, M; Giardina, JD; Giebultowicz, JM; Gifford, CA; Gijsen, FJH; Gilfillan, R; Gilson, E; Gingl, K; Giuliano, C; Glybochko, P; Goessler, W; Gofflot, S; Golab, J; Goldstein, A; Golebiowski, A; Gómez, L; Gómez-Carballo, J; Gonçalves, PEO; Gonzales, R; Gonzalez-Cotto, M; González-Fernández, D; Gonzalez-Lopez de Turiso, F; Goodman, JM; Govinda Raju, S; Grimm, J; Gross, AJ; Gruenheid, S; Gu, C; Gu, FF; Gu, S; Gu, Z; Guest, RL; Gui, C; Gui, J; Guillem, A; Guo, G; Guo, L; Guo, Q; Guo, S; Guo, SW; Guo, W; Guo, Y; Guo, YG; Guo, Z; Guretzky, JA; Haenggi, M; Hahn, MS; Hakkola, J; Halim, AA; Hampel, D; Han, B; Han, BH; Han, D; Han, G; Han, J; Han, LZ; Han, R; Han, S; Han, X; Han, Z; Handley, MA; Hanke, I; Hannongbua, S; Hao, P; Happ, JT; Hara, M; Haraux, F; Hare, JL; Harper, JD; Hartley, AM; Harvey, E; Hashimoto, K; Hassan, HM; Hautajärvi, H; Hayton, TW; He, C; He, H; He, HJ; He, WP; He, Y; He, Z; Hedrick, V; Heffernan, JK; Hegrová, J; Heidarimoghadam, R; Helms, K; Hengphasatporn, K; Henry, D; Herrmann, TRW; Hesson, T; Himmelbauer, MK; Hindle, A; Hoffmann, R; Hogg, N; Hong, KB; Hong, SK; Honjol, Y; Hood, C; Hsi, RS; Hsu, JL; Hu, B; Hu, BC; Hu, D; Hu, H; Hu, J; Hu, K; Hu, M; Hu, MK; Hu, T; Hu, W; Hu, Y; Hu, Z; Hua, S; Huang, H; Huang, J; Huang, L; Huang, M; Huang, P; Huang, X; Huang, Y; Huang, Z; Hukkanen, J; Hung, MC; Huo, X; Hyötyläinen, T; Ianiro, G; Ibanez, B; Imran, M; Ireland, S; Irwin, MS; Ishiguro, H; Jackowski, K; Jackson, C; Jacob, SI; Jahromy, MH; Jakob, SM; Jang, J; Javvaji, PK; Jefferson, KK; Jena, P; Ji, H; Jiang, F; Jiang, GH; Jiang, H; Jiang, J; Jiang, X; Jiang, Z; Jiao, J; Jiménez, A; Jin, X; Jincai, W; Jintao, X; Jo, K; Jofra, T; Johari, Y; Johnson, ACM; Jones, JH; Josephine Fauci, A; Juhl, AK; Jun, S; Kaiser, RI; Kajioka, J; Kajiyama, H; Kalliyil, A; Kalthur, SG; Kamalanathan, M; Kamaldinov, T; Kanaani, L; Kang, D; Kang, J; Kang, S; Känsäkoski, P; Kaplan, DL; Karwan, M; Kasibhatla, S; Kaur, A; Kawazoe, Y; Ke, C; Keyser, J; Khalique, A; Khan, IT; Kharshoum, RM; Kher, R; Kherani, J; Ki, KK; Kikkawa, F; Kikkawa, R; Kim, BT; Kim, EH; Kim, GA; Kim, GD; Kim, HB; Kim, HG; Kim, JS; Kim, MJ; Kim, SI; Kim, SJ; Kim, Y; King, K; Kinyamu-Akunda, J; Kirkkala, T; Kjaer-Sorensen, K; Kleppinger, EL; Kloner, RA; Klopfenstein, TJ; Knappe, D; Knezevic, P; Kobos, LM; Kohli, M; Kolano, L; Kolodgie, FD; Kolte, AP; Koneru, B; Kong, D; Kong, F; Kong, X; Konggidinata, MI; Köpke, M; Koski, KG; Kotsis, F; Köttgen, A; Kouakou-Kouamé, CA; Kraemer, US; Krane, V; Krehbiel, CR; Krenning, BJ; Kretzschmar, D; Ku, KB; Kubota, Y; Kulich, P; Kumar, NG; Kupiec-Weglinski, JW; Lalani, SS; Lan, X; Landfeldt, E; Langenberg, E; Lapauw, B; Larkin, J; Lassoued, MA; Laukhtina, E; Laura Martinez, J; Laveillé, A; Lavela, P; Law, AD; Lazraq, A; Le Foll, B; Lee, BK; Lee, C; Lee, CS; Lee, EJ; Lee, EY; Lee, G; Lee, HY; Lee, JH; Lee, JJ; Lee, JO; Lee, JS; Lee, R; Lei, H; Lei, P; Lellouche, F; Lennerz, JK; Leong, W; Leslie, I; Lessem, E; Levin, M; Levinger, I; Li, C; Li, CW; Li, CX; Li, CY; Li, D; Li, H; Li, HM; Li, J; Li, L; Li, LM; Li, N; Li, S; Li, W; Li, X; Li, XX; Li, Y; Li, Z; Li, ZL; Li, ZX; Lian, Q; Liang, C; Liang, GH; Liang, H; Liang, J; Liang, X; Liao, CX; Liao, R; Ličbinský, R; Lim, YS; Lima, HK; Lin, JG; Lin, L; Lin, S; Lin, WP; Lin, Z; Liso, M; Liu, BX; Liu, C; Liu, H; Liu, J; Liu, M; Liu, Q; Liu, S; Liu, SF; Liu, SL; Liu, T; Liu, W; Liu, X; Liu, XB; Liu, Y; Liu, YY; Liu, Z; Liu, ZQ; Lobo, M; Loitzenbauer, M; López, F; Lopez, G; López, GJ; Lou, Z; Lu, IC; Lu, J; Lu, M; Lu, W; Lu, X; Lu, Y; Luhovyy, BL; Luna-Abanto, J; Luo, J; Luo, K; Luo, L; Luo, M; Luo, W; Luo, X; Luo, XM; Lv, Y; Lv, YQ; Lyu, HD; Lyu, J; Ma, C; Ma, G; Ma, L; Ma, Q; Ma, X; Ma, Y; Macha, SJ; MacLean, E; Mahalapbutr, P; Maina, T; Malfait, F; Malfertheiner, MV; Malzert-Fréon, A; Mansouri, E; Mao, C; Marcellin, E; Marchiori, PER; Marcotte, DJ; Maréchal, A; Maric, N; Maris, JM; Maron, L; Marti, CN; Martínez-Milla, J; Mateo, J; Mather, K; Mathison, CJN; Matthay, MA; Maxwell, CL; Mazier, D; Mazumder, D; Mazurkiewicz, M; Mazzucchelli, TG; McAuley, DF; Mccoy, K; McVicar, DW; Mebel, AM; Mech, A; Meester, EJ; Meiselbach, H; Melero, I; Ménard, G; Meng, X; Mengya, Y; Merle, G; Meunier, B; Mfarrej, B; Mi, K; Migueliz, I; Mikuška, P; Miladi, K; Miletich, R; Millar, JE; Mills, MR; Milne, R; Minute, L; Misiak, M; Mo, F; Modi, A; Mok, F; Molina, C; Mollen, CJ; Molteni, V; Montalto, M; Montet, D; Monti, MC; Moor, MB; Moravec, P; Morsiani, C; Murillo, E; Murugan, P; Muslem, R; Myers, RK; N'guessan, FK; Nabil, H; Nadal, J; Nadeem, M; Nafady, MM; Nafie, MS; Nair, HP; Nakano, R; Nance, J; Naren, N; Neil, CJ; Nelson, J; Nery, FC; Netsch, C; Nguyen, TH; Ni, L; Ni, YX; Nie, W; Nielsen, LK; Nigam, K; Nikolayev, AA; Nishiyama, M; Niu, LL; Niu, PP; Nock, BA; Noer, PR; Noll, G; Noll, S; Norenberg, JP; Nowicka, J; Nutho, B; O'Connor, M; Obonyo, NG; Ochiai, T; Ochoa, MC; Oh, BL; Oh, S; Olczak, J; Olivares, X; Ommurugan, B; Oosthuizen, MC; Operario, D; Orešič, M; Oshima, K; Otano, I; Ou, Y; Owen, TW; Oxvig, C; Pacey, V; Pai, M; Paik, H; Paiva, R; Palmieri, EM; Palpant, N; Pan, L; Pan, Q; Panahi, S; Pang, B; Pang, ZC; Pannecouque, C; Paris, L; Park, D; Park, DJ; Park, E; Park, EC; Park, IH; Park, JH; Park, JI; Park, S; Passmore, MR; Pattaranggoon, NC; Paun, M; Pedersen, S; Pedron, J; Peng, M; Peng, X; Penzhorn, BL; Pérez-Camargo, D; Perez-Maldonado, R; Pérez-Vicente, C; Pham, TD; Pickering, L; Pickersgill, NA; Pinault, E; Pinotsis, N; Plan, M; Pocino, K; Poh, CL; Pons, EDC; Popoff, MR; Porri, D; Pourmand, A; Pratviel, G; Prudente, DO; Qi, H; Qi, N; Qian, LY; Qiao, L; Qiao, Q; Qin, QP; Qiu, N; Qiu, SW; Qu, F; Quan, M; Quigg, A; Raee, E; Raibaud, P; Ramanitrahasimbola, D; Rapoport, L; Rasby, RJ; Rasoanirina, BNV; Raspini, B; Ratner, JR; Razafindrakoto, Z; Redd, MA; Ren, H; Ren, N; Rey, J; Reynolds, CP; Rich, PR; Richards, CJ; Rigol, M; Rimoldi, S; Robert, P; Rodrigues, AE; Roe, JH; Rohde, S; Rokita, JL; Roland, J; Rombaut, L; Ronkainen, J; Rothenberg, SM; Roy, SC; Ruan, Z; Rucker, PV; Rueda, D; Ruhwald, M; Rungrotmongkol, T; Rupert, AS; Rusjan, P; Ryabov, AD; Rysä, J; Saad, NES; Sabioni, P; Sadow, PM; Sahai, N; Salem, HF; Salinas, B; Salonurmi, T; Samé Guerra, D; Sánchez, J; Sanchez-González, J; Sanmamed, MF; Sansores-Peraza, P; Santoro, JC; Santschi, PH; Saritas, T; Sarkisova, Y; Savolainen, MJ; Scherberich, JE; Schlom, DG; Schmelz, EM; Schmid, MC; Schneider, MP; Schumacher, S; Schwartz, JC; Schwartzer, JJ; Schwehr, K; Schweitzer, DH; Scott, ME; Sedky, NK; See Hoe, L; Sejian, V; Selvaraju, S; Sen, SK; Seo, G; Šerý, O; Settles, JA; Sfar, S; Shaffer, J; Shan, GL; Shang, Q; Shannahan, JH; Shao, B; Shao, H; Shao, J; Shao, ZH; Shasha, Y; Shaw, K; Sheeba, V; Shekar, K; Shen, G; Shen, H; Shen, XD; Shen, Y; Sherrell, PC; Shete, PB; Shi, AX; Shi, J; Shi, JH; Shi, S; Shi, X; Shigeta, Y; Shimbo, A; Shin, E; Sikka, N; Silhavy, TJ; Simanon, N; Simard, S; Simon, J; Simon, M; Simpson, SD; Simundic, AM; Since, M; Singh, B; Singhroy, DN; Sinisterra, OT; Smith, EH; Sobreira, TJP; Solanes, N; Somasundar, Y; Sommerer, C; Sonei, A; Song, B; Song, E; Song, J; Song, M; Song, Y; Soo Lee, M; Sorensen, MD; Sournia-Saquet, A; Spaepen, E; Spirk, D; Srivastava, S; Stancill, JS; Stanczak, PS; Starenki, D; Starr, F; Step, DL; Steubl, D; Stigliani, JL; Stráská, J; Sträter, N; Su, ZZ; Sudano, I; Suen, JY; Suh, HJ; Sui, ZY; Suico, JG; Suleiman, K; Sumon, K; Sun, HB; Sun, J; Sun, L; Sun, LL; Sun, M; Sun, Q; Sun, W; Sun, X; Sun, XF; Sun, Y; Sun, YB; Sun, YH; Sun, YN; Sun, Z; Sunada, K; Suzuki, S; Sylvan, JB; Takala, J; Talla, D; Tamir, Z; Tan, SJ; Tanda, S; Tang, H; Tang, J; Tang, LF; Tang, SJ; Tang, Y; Tao, FB; Tappel, R; Taratkin, M; Teijeira, Á; Tellew, JE; Thomas, AM; Thomas, SG; Thomson, SR; Tian, J; Tie, Y; Tirado, JL; Tolonen, A; Tosato, G; Tronnet, A; Tsai, S; Turtoi, A; Turtoi, E; Tvrdoňová, M; Tyagi, A; Tzou, DT; Uddin Ahmad, Z; Urias, E; Usawachintachit, M; Ustriyana, P; Utsumi, F; Vacca, M; Vaculovič, T; Vaidya, SS; Valentin, A; Valgepea, K; van den Berg, P; van den Bergh, JP; van der Heiden, K; van Gaalen, K; Van Gemert, W; van Haard, PMM; van Hest, JCM; Vecchiarelli, E; Večeřa, Z; Venkatesh, R; Verhaeghe, P; Verhagen, HJ; Vetter, JM; Vieira, D; Vilchez-Tschischke, JP; Villena-Gutierrez, R; Villoslada Terrones, V; Vital-Jacome, M; Voelkl, J; Vogel, K; Vogrin, S; Volke, D; von Bahr, V; Vysloužil, J; Wade, TL; Wagner-Gillespie, M; Walsh, SW; Wan, LJ; Wan, SP; Wang, AL; Wang, B; Wang, BY; Wang, C; Wang, D; Wang, F; Wang, H; Wang, HR; Wang, HY; Wang, J; Wang, JY; Wang, K; Wang, L; Wang, LF; Wang, P; Wang, Q; Wang, R; Wang, SF; Wang, SP; Wang, SR; Wang, T; Wang, W; Wang, WP; Wang, X; Wang, XJ; Wang, Y; Wang, YL; Wang, YN; Wáng, YXJ; Wang, Z; Wang, ZF; Wang, ZY; Waning, B; Warner, JM; Washington, SL; Watson, AK; Wei, B; Wei, C; Wei, F; Wei, X; Wei, Y; Wemhoff, AP; Wen, Z; Weng, TT; Wesdemiotis, C; Wheeler, DA; Wildner, M; Wilson, BK; Wirth, LJ; Wissler, M; Wu, F; Wu, G; Wu, J; Wu, KH; Wu, MC; Wu, P; Wu, PK; Wu, S; Wu, W; Wu, X; Wu, XP; Wu, Y; Wyatt, E; Wyllie, S; Xia, Y; Xiao, BH; Xiao, SZ; Xiao, W; Xiao, X; Xiao, Z; Xie, D; Xie, K; Xie, X; Xie, Y; Xie, YF; Xin, S; Xin, Z; Xing, Q; Xing, WQ; Xiong, D; Xiong, X; Xu, C; Xu, D; Xu, F; Xu, G; Xu, H; Xu, J; Xu, JY; Xu, L; Xu, N; Xu, W; Xu, X; Xu, Y; Xu, YM; Xue, H; Xue, J; Xue, Z; Yan, R; Yan, SQ; Yan, W; Yan, X; Yan, Z; Yang, C; Yang, D; Yang, F; Yang, FC; Yang, G; Yang, J; Yang, M; Yang, P; Yang, Q; Yang, R; Yang, S; Yang, SJ; Yang, TWW; Yang, X; Yang, Y; Yang, Z; Yao, C; Yao, L; Yao, LP; Yao, M; Yao, T; Yao, W; Yao, Y; Yaseen, T; Yazdani, V; Ye, J; Ye, S; Yerys, BE; Yi, HWL; Yi, JL; Yin, F; Yin, J; Yin, Y; Yin, Z; Yong, ZP; Yongli, S; Yoo, JS; Yoshikawa, N; You, Q; Yu, B; Yu, CQ; Yu, H; Yu, HG; Yu, J; Yu, L; Yu, Q; Yu, X; Yu, Y; Yu, YK; Yu, Z; Yuan, Q; Yuan, R; Yuan, W; Yuan, X; Yuan, Y; Zager, RA; Zagozdzon, A; Zaller, N; Zang, YP; Zappi, ME; Zelikoff, JT; Zeman, T; Zhai, X; Zhan, P; Zhang, B; Zhang, C; Zhang, G; Zhang, H; Zhang, HB; Zhang, J; Zhang, JS; Zhang, L; Zhang, M; Zhang, Q; Zhang, RX; Zhang, S; Zhang, T; Zhang, W; Zhang, WH; Zhang, X; Zhang, XX; Zhang, Y; Zhang, YQ; Zhang, YW; Zhang, Z; Zhang, ZH; Zhao, D; Zhao, FL; Zhao, K; Zhao, L; Zhao, M; Zhao, R; Zhao, S; Zhao, W; Zhao, WG; Zhao, X; Zhao, Y; Zheng, G; Zheng, J; Zheng, S; Zheng, W; Zheng, Y; Zheng, YG; Zhong, Z; Zhou, C; Zhou, D; Zhou, H; Zhou, HY; Zhou, L; Zhou, Q; Zhou, X; Zhou, Y; Zhou, YL; Zhou, Z; Zhu, J; Zhu, L; Zhu, N; Zhu, X; Zhu, XF; Zhu, Y; Zhu, Z | 1 |
| Jin, Y; Li, H; Lu, X; Wang, X; Zhang, Y; Zhao, L | 1 |
| Chaudhary, A; Choudhary, P; Gupta, A; Pahal, S; Singh, S | 1 |
| Broggini, ACS; Bueno-Junior, LS; Esteves, IM; Kandratavicius, L; Leite, JP; Lopes-Aguiar, C; Monteiro, MR; Romcy-Pereira, RN; Rossignoli, MT; Ruggiero, RN | 1 |
| Gräslund, A; Ilag, L; Jarvet, J; Luo, J; Österlund, N; Roos, PM; Sholts, SB; Wallin, C; Wärmländer, SKTS | 1 |
| Ibi, M; Iwata, K; Katsuyama, M; Matsumoto, M; Ohshima, Y; Yabe-Nishimura, C | 1 |
| Abagyan, A; Funkelstein, L; Hook, V; Mosier, C; Toneff, T; Ziegler, M | 1 |
| Arrazola, MS; Carvajal, FJ; Farias, GG; Godoy, JA; Inestrosa, NC; Rios, JA; Serrano, FG; Vargas, JY | 1 |
| Bergfors, A; Gillberg, PG; Marutle, A; Nennesmo, I; Ni, R; Nordberg, A; Voytenko, L; Yu, W | 1 |
| Kaakkola, S; Tuominen, R | 1 |
| Chen, M; Nguyen, HT | 1 |
| Boopathi, S; Kolandaivel, P | 1 |
| Durazzo, TC; Mattsson, N; Weiner, MW | 1 |
| Lombardo, S; Maskos, U | 1 |
| Brandsch, R; Hritcu, L; Mihasan, M; Stefan, M | 1 |
| Du, G; Gao, F; Jin, G; Qiao, Z; Qiu, J; Xue, M; Zhang, J; Zhang, Q; Zhu, L | 1 |
| Durazzo, TC; Meyerhoff, DJ; Murray, DE | 1 |
| Guo, CN; Liu, GL; Liu, WW; Sun, L; Zhao, SJ; Zhao, YB | 1 |
| Enomoto, S; Habara, S; Higaki, Y; Kamino, S; Matsuura, Y; Saji, H; Ueda, M; Watanabe, K | 1 |
| Fukushima, K; Miyamoto, N; Sawada, K; Yamazaki, K | 1 |
| Huang, SH; Jong, A; Li, L; Liu, L; Mao, DA; Wu, CH; Yu, J; Zhang, B | 1 |
| Chan, AL; Chien, YW; Jin Lin, S | 1 |
| Zhao, B | 1 |
| Dickerson, TJ; Janda, KD; Treweek, JB | 1 |
| Aleisa, AM; Alkadhi, KA; Salim, S; Srivareerat, M; Tran, TT | 1 |
| Burza, A; Grabowska, I; Kaliszan, M; Kaliszan, R; Radecka, H; Radecki, J | 1 |
| Deng, J; Fang, CQ; Gao, CY; Li, J; Shen, C; Wang, YJ; Xu, ZQ; Zhang, M; Zhou, HD | 1 |
| Alkadhi, KA; Srivareerat, M; Tran, TT | 1 |
| Choonara, YE; du Toit, LC; Kumar, P; Modi, G; Naidoo, D; Pillay, V | 1 |
| Alkadhi, KA; Alzoubi, KH; Srivareerat, M; Tran, TT | 2 |
| Bao, F; Klein, WL; Lacor, PN; Marutle, A; Nordberg, A; Wicklund, L | 1 |
| Cardinale, A; Cesario, A; Nastrucci, C; Russo, P | 1 |
| Kokare, DM; Nakhate, KT; Rangani, RJ; Subhedar, NK; Upadhya, MA | 1 |
| Grayson, L; Thomas, AJ | 1 |
| Aladellie, L; Almkvist, O; Almqvist, P; Andreasen, N; Blennow, K; Bogdanovic, N; Eriksdotter-Jönhagen, M; Jelic, V; Kadir, A; Lind, G; Linderoth, B; Nordberg, A; Seiger, A; Sundström, E; Wahlberg, L; Wahlund, LO; Wall, A; Wiberg, M; Winblad, B | 1 |
| Chen, M; Maleski, JJ; Nguyen, HT; Sawmiller, DR; Wu, Q | 1 |
| Appleby, BS; Cummings, JL; Milano, N; Nacopoulos, D; Zhong, K | 1 |
| Brown, D; Manaye, KF; Ramlochansingh, C; Tizabi, Y | 1 |
| Lok, K; Lu, J; Nie, H; Shen, H; Wang, Y; Wang, Z; Xu, Z; Yin, M; Zhang, C; Zhao, W | 1 |
| Liu, Y; Luo, P; Zuo, P | 1 |
| Hasegawa, K; Naiki, H; Ono, K; Yamada, M | 1 |
| Greig, NH; Haroutunian, V; Holloway, HW; Ingram, DK; Lahiri, DK; Sambamurti, K; Shoaib, M; Utsuki, T; Wallace, WC | 1 |
| Freir, DB; Herron, CE | 1 |
| Dickerson, TJ; Janda, KD | 1 |
| Hook, VY; Reisine, TD | 1 |
| Hellström-Lindahl, E; Mousavi, M; Nordberg, A; Ravid, R | 1 |
| Nagata, K | 1 |
| Damberg, P; Danielsson, J; Gräslund, A; Jarvet, J | 1 |
| Engeland, C; Ilivitsky, V; Knott, V; Mahoney, C; Mohr, E | 3 |
| Hernandez, CM; Terry, AV | 1 |
| Caccamo, A; Chen, Y; Green, KN; LaFerla, FM; Leslie, FM; Liang, K; Oddo, S; Tran, L | 1 |
| Levin, ED; McClernon, FJ; Rezvani, AH | 1 |
| Almkvist, O; Kadir, A; Långström, B; Nordberg, A; Wall, A | 1 |
| Cattaneo, A; Cherubini, E; Rosato-Siri, M | 1 |
| Chen, Q; Liu, Q; Qin, C; Zhang, J; Zhao, B; Zhu, H | 1 |
| Almkvist, O; Darreh-Shori, T; Kadir, A; Långström, B; Nordberg, A; Wall, A | 1 |
| Almkvist, O; Blomquist, G; Darreh-Shori, T; Grut, M; Kadir, A; Långström, B; Nordberg, A; Ringheim, A; Strandberg, B; Wall, A | 1 |
| Fedotova, YO; Kuznetsova, NN; Sapronov, NS | 1 |
| Stitzel, JA | 1 |
| Picciotto, MR; Zoli, M | 1 |
| Alvarez, I; Carmona, P; de Miguel, E; Rodríguez-Casado, A; Toledano, A | 1 |
| Bae, CJ; Chae, KR; Hwang, DY; Jee, SW; Kim, BG; Kim, CK; Kim, YK; Lee, BC; Lee, HH; Lee, SH; Shim, SB; Sin, JS | 1 |
| Clarke, PB; Pert, A; Pert, CB | 1 |
| Benson, DM; Ksir, C | 1 |
| Riekkinen, M; Riekkinen, P | 1 |
| Colquhoun, D; Sivilotti, L | 1 |
| Potter, PE; Thorne, B | 1 |
| Hartvig, P; Långström, B; Lilja, A; Lundqvist, H; Nordberg, A | 1 |
| Baldinger, SL; Schroeder, DJ | 1 |
| James, JR; Nordberg, A | 1 |
| Levin, ED; Rose, JE; Westman, EC | 1 |
| Brioni, JD; Buckley, MJ; Decker, MW; Giardina, WJ; Kang, CH; Kim, DJ; Radek, RJ; Raszkiewicz, JL; Sullivan, JP; Wasicak, JT | 1 |
| Arneric, SP; Giordano, T; Monteggia, LM | 1 |
| Coull, JT; Sahakian, BJ | 1 |
| Nordberg, A | 1 |
| Lawrence, AD; Sahakian, BJ | 1 |
| Arneric, SP; Bannon, AW; Briggs, CA; Brioni, JD; Decker, MW; Donnelly-Roberts, D; Kyncl, J; Marsh, KC; Radek, RJ; Sullivan, JP | 1 |
| Nordberg, A; Warpman, U | 1 |
| Lockhart, BP; Maurice, T; Privat, A | 1 |
| Friedland, RP; Marcinowski, KJ; Salomon, AR; Zagorski, MG | 1 |
| Becker, RE; Collins, GT; Danz, V; Gilbert, DG; Kabatay, E; Keim, P; Matthews, JR; Parks, RW; Rippey, RF; Urycki, PG; Vohs, C; Young, CS; Zigler, SS | 1 |
| Balfour, DJ; Fagerström, KO | 1 |
| Levin, ED; Newhouse, PA; Potter, A | 1 |
| Lindstrom, J | 1 |
| Akaike, A; Kihara, T; Kimura, J; Kume, T; Maeda, T; Sawada, H; Shimohama, S; Urushitani, M | 1 |
| Ikonen, S; Riekkinen, M; Riekkinen, P | 1 |
| Stephenson, J | 1 |
| Bogdanovic, N; Lannfelt, L; Marutle, A; Nordberg, A; Warpman, U | 1 |
| Hellström-Lindahl, E; Mousavi, M; Nordberg, A; Ravid, R; Zhang, X | 1 |
| Levin, ED; White, HK | 1 |
| Arendash, GW; Bjugstad, KB; Bridge, MH; Grossman, S; Huber, M; Linert, W | 1 |
| Gillberg, PG; Nordberg, A; Sihver, W; Svensson, AL | 1 |
| Beyreuther, K; Emilien, G; Maloteaux, JM; Masters, CL | 1 |
| Levin, ED; Rezvani, AH | 2 |
| Ballard, C; Buxbaum, JD; Clementi, F; Cohen, O; Court, J; Davis, K; Gotti, C; Griffiths, M; Haroutunian, V; Jaros, E; Johnson, M; Lee, M; Martin-Ruiz, C; McKeith, I; Nãsland, J; Perry, E; Perry, R; Piggott, M; Soreq, H; Tzartos, S | 1 |
| Hellström-Lindahl, E | 1 |
| Brayne, C | 1 |
| López-Arrieta, JM; Rodríguez, JL; Sanz, F | 2 |
| Ballard, CG; Cookson, N; Court, JA; Lloyd, S; McKeith, IG; Perry, EK; Perry, RH; Piggott, MA | 1 |
| Allen, DD; Arriagada, C; Cárdenas, AM; Caviedes, P; Caviedes, R; Martín, J; Rapoport, SI | 1 |
| Rattray, M | 1 |
| Allen, YS; Zamani, MR | 1 |
| Kihara, T; Shimohama, S | 1 |
| Chang, K; Choi, SH; Jeong, S; Kim, E; Kim, H; Kim, S; Koo, J; Lee, J; Park, CH; Rah, J; Seo, J; Suh, Y | 1 |
| Freidland, RP; Menon, NK; Peng, L; Salomon, AR; Shao, H; Yang, J; Zagorski, MG; Zeng, H; Zhang, Y | 1 |
| Corwin, J; Kelton, M; Newhouse, PA; Potter, A | 1 |
| Drucker-Colín, R; Mihailescu, S | 1 |
| Lodge, D | 1 |
| Ashe, KH; Bell, K; Bui, D; Dineley, KT; Sweatt, JD; Westerman, M | 1 |
| Danysz, W | 1 |
| Levine, MD; Peskind, E; Rosin, RA | 1 |
| Arthur, D; Levin, ED | 1 |
| Engeland, C; Ilivitsky, V; Knott, VJ; Mahoney, C; Mohr, E | 1 |
| Schub, T | 1 |
| Hiramatsu, M; Kameyama, T; Nabeshima, T; Yamatsu, T | 1 |
| Howe, MN; Price, IR | 1 |
| Abeles, N; Murray, KN | 1 |
| Hashimoto, K; Iyo, M | 1 |
| Nyberg-Swenson, BE | 1 |
| Bednar, I; Court, J; Hall, R; Hellström-Lindahl, E; Johnson, M; Lee, M; Mousavi, M; Nordberg, A; Perry, E | 1 |
| Gray, JA; Jones, GM; Levy, R; Sahakian, BJ; Warburton, DM | 1 |
| Alafuzoff, I; Amberla, K; Bäckman, L; Ebendal, T; Hartvig, P; Herlitz, A; Lilja, A; Nordberg, A; Olson, L; von Holst, H | 1 |
| Anderson, DJ; Decker, MW; Majchrzak, MJ | 1 |
| Amberla, K; Anderson, Y; Andersson, J; Hartvig, P; Lilja, A; Lundqvist, H; Nordberg, A; Nybäck, H; Ulin, J; Viitanen, M | 1 |
| Araujo, DM; Aubert, I; Cécyre, D; Gauthier, S; Quirion, R; Robitaille, Y | 1 |
| Benowitz, NL; Le Houezec, J | 1 |
| Hofman, A; van Duijn, CM | 1 |
| Lönnberg, P; Marjamäki, P; Myllykylä, T; Rinne, JO | 1 |
| Hardy, J; Harrison, PJ; Mullan, M; Pearson, RC | 1 |
| Mokrasch, LC | 1 |
| Fertig, JB; Lawlor, BA; Mellow, AM; Murphy, DL; Narang, PK; Newhouse, PA; Sunderland, T | 1 |
| Chiappinelli, VA; Giacobini, E; Sugaya, K | 1 |
| Bhat, RV; Collins, AC; Marks, MJ; Turner, SL | 1 |
| Amberla, K; Andersson, Y; Hartvig, P; Långström, B; Lilja, A; Lundqvist, H; Nordberg, A; Ulin, J; Viitanen, M; Winblad, B | 1 |
| Jones, G; Levy, R; Sahakian, B | 1 |
| Gray, J; Jones, G; Levy, R; Sahakian, B; Warburton, D | 1 |
| Balfour, DJ; Grant, DJ; McMurdo, ME | 1 |
| Ball, MJ; London, ED; Waller, SB | 1 |
| Robbins, TW | 1 |
| Blessed, G; Candy, JM; Dick, DJ; Edwardson, JA; Fairbairn, A; Perry, EK; Perry, RH; Smith, CJ | 1 |
| Blumhardt, CL; Mellow, A; Murphy, DL; Newhouse, PA; Sunderland, T; Tariot, PN; Weingartner, H | 1 |
| Adem, A; Hardy, J; Nordberg, A; Winblad, B | 1 |
| Kellar, KJ; Marcus, KA; Martino, AM; Price, DL; Singer, HS; Whitehouse, PJ; Zweig, RM | 1 |
| Antuono, PG; Coyle, JT; Kellar, KJ; Lowenstein, PR; Martino, AM; Price, DL; Whitehouse, PJ | 1 |
| Flynn, DD; Mash, DC | 1 |
| Cohen, RM; Mueller, ER; Murphy, DL; Newhouse, PA; Sunderland, T; Tariot, PN; Thompson, K; Weingartner, H | 1 |
33 review(s) available for nicotine and Alzheimer Disease
| Article | Year |
|---|---|
Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor Proteins, Signal Transducing; Adenine; Adenocarcinoma; Adipogenesis; Administration, Cutaneous; Administration, Ophthalmic; Adolescent; Adsorption; Adult; Aeromonas hydrophila; Aerosols; Aged; Aged, 80 and over; Aging; Agriculture; Air Pollutants; Air Pollution; Airway Remodeling; Alanine Transaminase; Albuminuria; Aldehyde Dehydrogenase 1 Family; Algorithms; AlkB Homolog 2, Alpha-Ketoglutarate-Dependent Dioxygenase; Alzheimer Disease; Amino Acid Sequence; Ammonia; Ammonium Compounds; Anaerobiosis; Anesthetics, Dissociative; Anesthetics, Inhalation; Animals; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antigens, Bacterial; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antitubercular Agents; Antiviral Agents; Apolipoproteins E; Apoptosis; Arabidopsis; Arabidopsis Proteins; Arsenic; Arthritis, Rheumatoid; Asthma; Atherosclerosis; ATP-Dependent Proteases; Attitude of Health Personnel; Australia; Austria; Autophagy; Axitinib; Bacteria; Bacterial Outer Membrane Proteins; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; Bariatric Surgery; Base Composition; Bayes Theorem; Benzoxazoles; Benzylamines; beta Catenin; Betacoronavirus; Betula; Binding Sites; Biological Availability; Biological Oxygen Demand Analysis; Biomarkers; Biomarkers, Tumor; Biopsy; Bioreactors; Biosensing Techniques; Birth Weight; Blindness; Blood Chemical Analysis; Blood Gas Analysis; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Blood-Brain Barrier; Blotting, Western; Body Mass Index; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Borates; Brain; Brain Infarction; Brain Injuries, Traumatic; Brain Neoplasms; Breakfast; Breast Milk Expression; Breast Neoplasms; Bronchi; Bronchoalveolar Lavage Fluid; Buffaloes; Cadherins; Calcification, Physiologic; Calcium Compounds; Calcium, Dietary; Cannula; Caprolactam; Carbon; Carbon Dioxide; Carboplatin; Carcinogenesis; Carcinoma, Ductal; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Cardiovascular Diseases; Carps; Carrageenan; Case-Control Studies; Catalysis; Catalytic Domain; Cattle; CD8-Positive T-Lymphocytes; Cell Adhesion; Cell Cycle Proteins; Cell Death; Cell Differentiation; Cell Line; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Phone Use; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cell Transformation, Viral; Cells, Cultured; Cellulose; Chemical Phenomena; Chemoradiotherapy; Child; Child Development; Child, Preschool; China; Chitosan; Chlorocebus aethiops; Cholecalciferol; Chromatography, Liquid; Circadian Clocks; Circadian Rhythm; Circular Dichroism; Cisplatin; Citric Acid; Clinical Competence; Clinical Laboratory Techniques; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clostridioides difficile; Clostridium Infections; Coculture Techniques; Cohort Studies; Cold Temperature; Colitis; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type XI; Color; Connective Tissue Diseases; Copper; Coronary Angiography; Coronavirus 3C Proteases; Coronavirus Infections; Cost of Illness; Counselors; COVID-19; COVID-19 Testing; Creatine Kinase; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Cryoelectron Microscopy; Cryosurgery; Crystallography, X-Ray; Cues; Cultural Competency; Cultural Diversity; Curriculum; Cyclic AMP Response Element-Binding Protein; Cyclin-Dependent Kinase Inhibitor p21; Cycloparaffins; Cysteine Endopeptidases; Cytokines; Cytoplasm; Cytoprotection; Databases, Factual; Denitrification; Deoxycytidine; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diagnosis, Differential; Diatoms; Diet; Diet, High-Fat; Dietary Exposure; Diffusion Magnetic Resonance Imaging; Diketopiperazines; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Disease Progression; Disease-Free Survival; DNA; DNA Damage; DNA Glycosylases; DNA Repair; DNA-Binding Proteins; DNA, Bacterial; DNA, Viral; Docetaxel; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Drosophila; Drosophila melanogaster; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Repositioning; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; Edema; Edible Grain; Education, Graduate; Education, Medical, Graduate; Education, Pharmacy; Ehlers-Danlos Syndrome; Electron Transport Complex III; Electron Transport Complex IV; Electronic Nicotine Delivery Systems; Emergency Service, Hospital; Empathy; Emulsions; Endothelial Cells; Endurance Training; Energy Intake; Enterovirus A, Human; Environment; Environmental Monitoring; Enzyme Assays; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Epoxide Hydrolases; Epoxy Compounds; Erythrocyte Count; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Estrogens; Etanercept; Ethiopia; Ethnicity; Ethylenes; Exanthema; Exercise; Exercise Test; Exercise Tolerance; Extracellular Matrix; Extracorporeal Membrane Oxygenation; Eye Infections, Fungal; False Negative Reactions; Fatty Acids; Fecal Microbiota Transplantation; Feces; Female; Femur Neck; Fermentation; Ferritins; Fetal Development; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibroblasts; Fibroins; Fish Proteins; Flavanones; Flavonoids; Focus Groups; Follow-Up Studies; Food Handling; Food Supply; Food, Formulated; Forced Expiratory Volume; Forests; Fractures, Bone; Fruit and Vegetable Juices; Fusobacteria; G1 Phase Cell Cycle Checkpoints; G2 Phase Cell Cycle Checkpoints; Gamma Rays; Gastrectomy; Gastrointestinal Microbiome; Gastrointestinal Stromal Tumors; Gefitinib; Gels; Gemcitabine; Gene Amplification; Gene Expression; Gene Expression Regulation; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Gene-Environment Interaction; Genotype; Germany; Glioma; Glomerular Filtration Rate; Glucagon; Glucocorticoids; Glycemic Control; Glycerol; Glycogen Synthase Kinase 3 beta; Glycolipids; Glycolysis; Goblet Cells; Gram-Negative Bacterial Infections; Granulocyte Colony-Stimulating Factor; Graphite; Greenhouse Effect; Guanidines; Haemophilus influenzae; HCT116 Cells; Health Knowledge, Attitudes, Practice; Health Personnel; Health Services Accessibility; Health Services Needs and Demand; Health Status Disparities; Healthy Volunteers; Heart Failure; Heart Rate; Heart Transplantation; Heart-Assist Devices; HEK293 Cells; Heme; Heme Oxygenase-1; Hemolysis; Hemorrhage; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Hexoses; High-Throughput Nucleotide Sequencing; Hippo Signaling Pathway; Histamine; Histamine Agonists; Histidine; Histone Deacetylase 2; HIV Infections; HIV Reverse Transcriptase; HIV-1; Homebound Persons; Homeodomain Proteins; Homosexuality, Male; Hospice and Palliative Care Nursing; HSP70 Heat-Shock Proteins; Humans; Hyaluronan Receptors; Hydrogen; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrolysis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemia; Hypoglycemic Agents; Hypoxia; Idiopathic Interstitial Pneumonias; Imaging, Three-Dimensional; Imatinib Mesylate; Immunotherapy; Implementation Science; Incidence; INDEL Mutation; Induced Pluripotent Stem Cells; Industrial Waste; Infant; Infant, Newborn; Inflammation; Inflammation Mediators; Infliximab; Infusions, Intravenous; Inhibitory Concentration 50; Injections; Insecticides; Insulin-Like Growth Factor Binding Protein 5; Insulin-Secreting Cells; Interleukin-1; Interleukin-17; Interleukin-8; Internship and Residency; Intestines; Intracellular Signaling Peptides and Proteins; Ion Transport; Iridaceae; Iridoid Glucosides; Islets of Langerhans Transplantation; Isodon; Isoflurane; Isotopes; Italy; Joint Instability; Ketamine; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Kidney Neoplasms; Kinetics; Klebsiella pneumoniae; Knee Joint; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Lactate Dehydrogenase 5; Laparoscopy; Laser Therapy; Lasers, Semiconductor; Lasers, Solid-State; Laurates; Lead; Leukocyte L1 Antigen Complex; Leukocytes, Mononuclear; Light; Lipid Peroxidation; Lipopolysaccharides; Liposomes; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Locomotion; Longitudinal Studies; Lopinavir; Lower Urinary Tract Symptoms; Lubricants; Lung; Lung Diseases, Interstitial; Lung Neoplasms; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Lymphoma, Mantle-Cell; Lysosomes; Macrophages; Male; Manganese Compounds; MAP Kinase Kinase 4; Mass Screening; Maternal Health; Medicine, Chinese Traditional; Melanoma, Experimental; Memantine; Membrane Glycoproteins; Membrane Proteins; Mesenchymal Stem Cell Transplantation; Metal Nanoparticles; Metalloendopeptidases; Metalloporphyrins; Methadone; Methane; Methicillin-Resistant Staphylococcus aureus; Mexico; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Mice, Nude; Mice, SCID; Mice, Transgenic; Microarray Analysis; Microbial Sensitivity Tests; Microbiota; Micronutrients; MicroRNAs; Microscopy, Confocal; Microsomes, Liver; Middle Aged; Milk; Milk, Human; Minority Groups; Mitochondria; Mitochondrial Membranes; Mitochondrial Proteins; Models, Animal; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Epidemiology; Molecular Structure; Molecular Weight; Multilocus Sequence Typing; Multimodal Imaging; Muscle Strength; Muscle, Skeletal; Muscular Diseases; Mutation; Mycobacterium tuberculosis; Myocardial Stunning; Myristates; NAD(P)H Dehydrogenase (Quinone); Nanocomposites; Nanogels; Nanoparticles; Nanotechnology; Naphthalenes; Nasal Cavity; National Health Programs; Necrosis; Needs Assessment; Neoadjuvant Therapy; Neonicotinoids; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm Transplantation; Neoplasms; Neoplastic Stem Cells; Netherlands; Neuroblastoma; Neuroprotective Agents; Neutrophils; NF-kappa B; NFATC Transcription Factors; Nicotiana; Nicotine; Nitrates; Nitrification; Nitrites; Nitro Compounds; Nitrogen; Nitrogen Dioxide; North Carolina; Nuclear Magnetic Resonance, Biomolecular; Nuclear Proteins; Nucleic Acid Hybridization; Nucleosomes; Nutrients; Obesity; Obesity, Morbid; Oceans and Seas; Oncogene Protein v-akt; Oncogenes; Oocytes; Open Reading Frames; Osteoclasts; Osteogenesis; Osteoporosis; Osteoporosis, Postmenopausal; Outpatients; Ovarian Neoplasms; Ovariectomy; Overweight; Oxazines; Oxidants; Oxidation-Reduction; Oxidative Stress; Oxides; Oxidoreductases; Oxygen; Oxygen Inhalation Therapy; Oxygenators, Membrane; Ozone; Paclitaxel; Paenibacillus; Pain Measurement; Palliative Care; Pancreatic Neoplasms; Pandemics; Parasympathetic Nervous System; Particulate Matter; Pasteurization; Patient Preference; Patient Satisfaction; Pediatric Obesity; Permeability; Peroxiredoxins; Peroxynitrous Acid; Pharmaceutical Services; Pharmacists; Pharmacy; Phaseolus; Phenotype; Phoeniceae; Phosphates; Phosphatidylinositol 3-Kinases; Phospholipid Transfer Proteins; Phospholipids; Phosphorus; Phosphorylation; Photoperiod; Photosynthesis; Phylogeny; Physical Endurance; Physicians; Pilot Projects; Piperidines; Pituitary Adenylate Cyclase-Activating Polypeptide; Plant Extracts; Plant Leaves; Plant Proteins; Plant Roots; Plaque, Atherosclerotic; Pneumonia; Pneumonia, Viral; Point-of-Care Testing; Polyethylene Glycols; Polymers; Polysorbates; Pore Forming Cytotoxic Proteins; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postprandial Period; Poverty; Pre-Exposure Prophylaxis; Prediabetic State; Predictive Value of Tests; Pregnancy; Pregnancy Trimester, First; Pregnancy, High-Risk; Prenatal Exposure Delayed Effects; Pressure; Prevalence; Primary Graft Dysfunction; Primary Health Care; Professional Role; Professionalism; Prognosis; Progression-Free Survival; Prolactin; Promoter Regions, Genetic; Proof of Concept Study; Proportional Hazards Models; Propylene Glycol; Prospective Studies; Prostate; Protein Binding; Protein Biosynthesis; Protein Isoforms; Protein Kinase Inhibitors; Protein Phosphatase 2; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Protein Transport; Proteoglycans; Proteome; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins c-ret; Proto-Oncogene Proteins p21(ras); Proton Pumps; Protons; Protoporphyrins; Pseudomonas aeruginosa; Pseudomonas fluorescens; Pulmonary Artery; Pulmonary Disease, Chronic Obstructive; Pulmonary Gas Exchange; Pulmonary Veins; Pyrazoles; Pyridines; Pyrimidines; Qualitative Research; Quinoxalines; Rabbits; Random Allocation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Histamine H3; Receptors, Immunologic; Receptors, Transferrin; Recombinant Proteins; Recurrence; Reference Values; Referral and Consultation; Regional Blood Flow; Registries; Regulon; Renal Insufficiency, Chronic; Reperfusion Injury; Repressor Proteins; Reproducibility of Results; Republic of Korea; Research Design; Resistance Training; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Insufficiency; Resuscitation; Retinal Dehydrogenase; Retreatment; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Ribosomal Proteins; Ribosomes; Risk Assessment; Risk Factors; Ritonavir; Rivers; RNA Interference; RNA-Seq; RNA, Messenger; RNA, Ribosomal, 16S; RNA, Small Interfering; Rosuvastatin Calcium; Rural Population; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salivary Ducts; Salivary Gland Neoplasms; San Francisco; SARS-CoV-2; Satiation; Satiety Response; Schools; Schools, Pharmacy; Seasons; Seawater; Selection, Genetic; Sequence Analysis, DNA; Serine-Threonine Kinase 3; Sewage; Sheep; Sheep, Domestic; Shock, Hemorrhagic; Signal Transduction; Silver; Silymarin; Single Photon Emission Computed Tomography Computed Tomography; Sirolimus; Sirtuin 1; Skin; Skin Neoplasms; Skin Physiological Phenomena; Sleep Initiation and Maintenance Disorders; Social Class; Social Participation; Social Support; Soil; Soil Microbiology; Solutions; Somatomedins; Soot; Specimen Handling; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spinal Fractures; Spirometry; Staphylococcus aureus; STAT1 Transcription Factor; STAT3 Transcription Factor; Streptomyces coelicolor; Stress, Psychological; Stroke; Stroke Volume; Structure-Activity Relationship; Students, Medical; Students, Pharmacy; Substance Abuse Treatment Centers; Sulfur Dioxide; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Analysis; Survival Rate; Survivin; Sweden; Swine; Swine, Miniature; Sympathetic Nervous System; T-Lymphocytes, Regulatory; Talaromyces; Tandem Mass Spectrometry; tau Proteins; Telemedicine; Telomerase; Telomere; Telomere Homeostasis; Temperature; Terminally Ill; Th1 Cells; Thiamethoxam; Thiazoles; Thiophenes; Thioredoxin Reductase 1; Thrombosis; Thulium; Thyroid Cancer, Papillary; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Time Factors; Titanium; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Transcription Factor AP-1; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transcriptome; Transforming Growth Factor beta1; Transistors, Electronic; Translational Research, Biomedical; Transplantation Tolerance; Transplantation, Homologous; Transportation; Treatment Outcome; Tretinoin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Tubulin Modulators; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Twins; Ultrasonic Therapy; Ultrasonography; Ultraviolet Rays; United States; Up-Regulation; Uranium; Urethra; Urinary Bladder; Urodynamics; Uromodulin; Uveitis; Vasoconstrictor Agents; Ventricular Function, Left; Vero Cells; Vesicular Transport Proteins; Viral Nonstructural Proteins; Visual Acuity; Vital Capacity; Vitamin D; Vitamin D Deficiency; Vitamin K 2; Vitamins; Volatilization; Voriconazole; Waiting Lists; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Whole Genome Sequencing; Wine; Wnt Signaling Pathway; Wound Healing; Wounds and Injuries; WW Domains; X-linked Nuclear Protein; X-Ray Diffraction; Xanthines; Xenograft Model Antitumor Assays; YAP-Signaling Proteins; Yogurt; Young Adult; Zebrafish; Zebrafish Proteins; Ziziphus | 2016 |
[Nicotine and neurologic diseases--even a noxious substance may possess beneficial properties].
Topics: Alzheimer Disease; Ataxia; Benzazepines; Cognitive Dysfunction; Epilepsy, Frontal Lobe; Humans; Mutation; Nicotine; Nicotinic Agonists; Parkinson Disease; Quinoxalines; Receptors, Nicotinic; Tobacco Use Cessation Devices; Varenicline | 2013 |
Smoking and increased Alzheimer's disease risk: a review of potential mechanisms.
Topics: Alzheimer Disease; Animals; Brain; Humans; Nicotine; Nicotinic Agonists; Oxidative Stress; Risk Factors; Smoking | 2014 |
Role of the nicotinic acetylcholine receptor in Alzheimer's disease pathology and treatment.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain; Disease Models, Animal; Humans; Mice, Transgenic; Neurons; Nicotine; Nicotinic Agonists; Receptors, Muscarinic; Receptors, Nicotinic | 2015 |
Transdermal delivery of treatment for Alzheimer's disease: development, clinical performance and future prospects.
Topics: Administration, Cutaneous; Alzheimer Disease; Cholinesterase Inhibitors; Clinical Trials as Topic; Drug Design; Estrogens; Humans; Muscarinic Agonists; Nicotine; Skin Absorption | 2008 |
Natural antioxidants protect neurons in Alzheimer's disease and Parkinson's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Flavonoids; Neurons; Nicotine; Oxidative Stress; Parkinson Disease; Phenols; Plaque, Amyloid; Polyphenols; Tea | 2009 |
Nicotine: specific role in angiogenesis, proliferation and apoptosis.
Topics: Alzheimer Disease; Animals; Apoptosis; Cell Proliferation; Humans; Neovascularization, Pathologic; Neuroprotective Agents; Nicotine; Parkinson Disease; Protein Binding; Receptors, Nicotinic | 2012 |
A review: treatment of Alzheimer's disease discovered in repurposed agents.
Topics: Aged; Alzheimer Disease; Anti-Asthmatic Agents; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants; Antidepressive Agents; Antihypertensive Agents; Antineoplastic Agents; Antiparkinson Agents; Antipsychotic Agents; Drug Discovery; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Methylene Blue; Nicotine; Nicotinic Agonists | 2013 |
[Cigarette smoking and neurological disease].
Topics: Alzheimer Disease; Amyotrophic Lateral Sclerosis; Cerebrovascular Circulation; Humans; Intracranial Arteriosclerosis; Multiple Sclerosis; Nicotine; Parkinson Disease; Risk Factors; Smoking; Stroke | 2004 |
Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Alzheimer Disease; Amygdala; Animals; Attention; Cognition; Hippocampus; Humans; Learning; Memory; Mice; Nicotine; Rats; Receptors, Nicotinic; Schizophrenia | 2006 |
Naturally occurring genetic variability in the nicotinic acetylcholine receptor alpha4 and alpha7 subunit genes and phenotypic diversity in humans and mice.
Topics: Alcoholism; alpha7 Nicotinic Acetylcholine Receptor; Alzheimer Disease; Animals; Epilepsy; Gene Expression Regulation; Genetic Variation; Humans; Mice; Models, Biological; Nicotine; Phenotype; Polymorphism, Genetic; Receptors, Nicotinic; Species Specificity | 2008 |
Neuroprotection via nAChRs: the role of nAChRs in neurodegenerative disorders such as Alzheimer's and Parkinson's disease.
Topics: Alzheimer Disease; Animals; Binding Sites; Brain; Humans; Models, Biological; Neurodegenerative Diseases; Neuroprotective Agents; Nicotine; Parkinson Disease; Receptors, Nicotinic; Signal Transduction | 2008 |
Nicotine therapy in patients with Alzheimer's disease.
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Alzheimer Disease; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Nicotine | 1995 |
Genetic and environmental aspects of the role of nicotinic receptors in neurodegenerative disorders: emphasis on Alzheimer's disease and Parkinson's disease.
Topics: Aging; Alzheimer Disease; Animals; Brain Chemistry; Drug Tolerance; Female; Humans; Male; Nerve Degeneration; Nicotine; Parkinson Disease; Receptors, Nicotinic; Sex Factors; Signal Transduction; Up-Regulation | 1995 |
Nicotine as a therapeutic drug.
Topics: Alzheimer Disease; Colitis, Ulcerative; Humans; Nicotine; Parkinson Disease | 1995 |
Increased regional cerebral glucose metabolism and semantic memory performance in Alzheimer's disease: a pilot double blind transdermal nicotine positron emission tomography study.
Topics: Alzheimer Disease; Double-Blind Method; Glucose; Humans; Memory; Nicotine | 1996 |
Pharmacology of nicotine and its therapeutic use in smoking cessation and neurodegenerative disorders.
Topics: Alzheimer Disease; Animals; Behavior, Animal; Clinical Trials as Topic; Drug Carriers; Humans; Nicotine; Nicotinic Agonists; Parkinson Disease; Receptors, Nicotinic; Smoking Cessation; Substance Withdrawal Syndrome; Substance-Related Disorders | 1996 |
Nicotinic system involvement in Alzheimer's and Parkinson's diseases. Implications for therapeutics.
Topics: Alzheimer Disease; Animals; Cognition; Cognition Disorders; Combined Modality Therapy; Disease Models, Animal; Humans; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Parkinson Disease; Receptors, Nicotinic | 1997 |
Nicotinic acetylcholine receptors in health and disease.
Topics: Acetylcholine; Alzheimer Disease; Anesthetics; Animals; Autoimmune Diseases; Cholinergic Agents; Cholinergic Antagonists; Epilepsy; Ethanol; Female; Keratinocytes; Male; Models, Molecular; Muscle Proteins; Myasthenia Gravis; Nerve Tissue Proteins; Neuromuscular Junction; Nicotine; Parkinson Disease; Pregnancy; Protein Conformation; Receptors, Nicotinic; Schizophrenia; Smoking; Torpedo; Tourette Syndrome | 1997 |
Prospects for pharmacological intervention in Alzheimer disease.
Topics: Alzheimer Disease; Amyloid Precursor Protein Secretases; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Aspartic Acid Endopeptidases; Cholinesterase Inhibitors; Clinical Trials as Topic; Donepezil; Endopeptidases; Hippocampus; Humans; Indans; N-Methylaspartate; Nerve Growth Factors; Nicotine; Piperidines; Tacrine | 2000 |
Modulation of beta-amyloid precursor protein processing and tau phosphorylation by acetylcholine receptors.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Humans; Neuroprotective Agents; Neurotransmitter Agents; Nicotine; Nicotinic Agonists; Phosphorylation; Receptors, Cholinergic; Receptors, Muscarinic; Smoking; tau Proteins | 2000 |
Nicotine for Alzheimer's disease.
Topics: Alzheimer Disease; Cognition Disorders; Humans; Nicotine; Nicotinic Agonists | 2000 |
Is there nicotinic modulation of nerve growth factor? Implications for cholinergic therapies in Alzheimer's disease.
Topics: Acetylcholine; Aged; Alzheimer Disease; Animals; Gene Expression Regulation; Hippocampus; Humans; Nerve Growth Factor; Nicotine; Receptor, trkA | 2001 |
Nicotine and its interaction with beta-amyloid protein: a short review.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain; Humans; Nicotine; Receptors, Nicotinic | 2001 |
Nicotinic receptor-mediated protection against beta-amyloid neurotoxicity.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain; Cell Death; Humans; Nicotine; Receptors, Nicotinic | 2001 |
Cognitive effects of nicotine.
Topics: Adult; Aged; Alzheimer Disease; Animals; Cognition Disorders; Hippocampus; Humans; Neuropsychological Tests; Nicotine; Receptors, Nicotinic; Treatment Outcome | 2001 |
Nicotinic treatment of Alzheimer's disease.
Topics: Alzheimer Disease; Cholinergic Agents; Clinical Trials as Topic; Humans; Neuropsychological Tests; Nicotine; Receptors, Nicotinic; Treatment Outcome | 2001 |
Nicotine and brain disorders.
Topics: Alzheimer Disease; Animals; Attention Deficit Disorder with Hyperactivity; Humans; Nicotine; Parkinson Disease; Receptors, Nicotinic; Schizophrenia | 2000 |
Efficacy and safety of nicotine on Alzheimer's disease patients.
Topics: Alzheimer Disease; Double-Blind Method; Humans; Nicotine; Nicotinic Agonists; Randomized Controlled Trials as Topic | 2001 |
Neurotoxicity as a mechanism for neurodegenerative disorders: basic and clinical aspects.
Topics: Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Humans; Levodopa; Nerve Growth Factor; Neuroprotective Agents; Nicotine; Parkinson Disease | 2001 |
Nicotine's effect on neural and cognitive functioning in an aging population.
Topics: Aged; Aging; Alzheimer Disease; Cognition; Cognition Disorders; Ganglionic Stimulants; Humans; Neurons; Nicotine; Receptors, Nicotinic | 2002 |
[Amyloid cascade hypothesis of Alzheimer's disease and alpha 7 nicotinic receptor].
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Humans; Ligands; Nicotine; Nicotinic Agonists; Receptors, Nicotinic; Signal Transduction | 2002 |
Basic and clinical psychopharmacology of nicotine.
Topics: Alzheimer Disease; Animals; Electroencephalography; Evoked Potentials; Humans; Mental Processes; Nicotine; Parkinson Disease; Receptors, Nicotinic | 1991 |
14 trial(s) available for nicotine and Alzheimer Disease
| Article | Year |
|---|---|
Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor Proteins, Signal Transducing; Adenine; Adenocarcinoma; Adipogenesis; Administration, Cutaneous; Administration, Ophthalmic; Adolescent; Adsorption; Adult; Aeromonas hydrophila; Aerosols; Aged; Aged, 80 and over; Aging; Agriculture; Air Pollutants; Air Pollution; Airway Remodeling; Alanine Transaminase; Albuminuria; Aldehyde Dehydrogenase 1 Family; Algorithms; AlkB Homolog 2, Alpha-Ketoglutarate-Dependent Dioxygenase; Alzheimer Disease; Amino Acid Sequence; Ammonia; Ammonium Compounds; Anaerobiosis; Anesthetics, Dissociative; Anesthetics, Inhalation; Animals; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antigens, Bacterial; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antitubercular Agents; Antiviral Agents; Apolipoproteins E; Apoptosis; Arabidopsis; Arabidopsis Proteins; Arsenic; Arthritis, Rheumatoid; Asthma; Atherosclerosis; ATP-Dependent Proteases; Attitude of Health Personnel; Australia; Austria; Autophagy; Axitinib; Bacteria; Bacterial Outer Membrane Proteins; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; Bariatric Surgery; Base Composition; Bayes Theorem; Benzoxazoles; Benzylamines; beta Catenin; Betacoronavirus; Betula; Binding Sites; Biological Availability; Biological Oxygen Demand Analysis; Biomarkers; Biomarkers, Tumor; Biopsy; Bioreactors; Biosensing Techniques; Birth Weight; Blindness; Blood Chemical Analysis; Blood Gas Analysis; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Blood-Brain Barrier; Blotting, Western; Body Mass Index; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Borates; Brain; Brain Infarction; Brain Injuries, Traumatic; Brain Neoplasms; Breakfast; Breast Milk Expression; Breast Neoplasms; Bronchi; Bronchoalveolar Lavage Fluid; Buffaloes; Cadherins; Calcification, Physiologic; Calcium Compounds; Calcium, Dietary; Cannula; Caprolactam; Carbon; Carbon Dioxide; Carboplatin; Carcinogenesis; Carcinoma, Ductal; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Cardiovascular Diseases; Carps; Carrageenan; Case-Control Studies; Catalysis; Catalytic Domain; Cattle; CD8-Positive T-Lymphocytes; Cell Adhesion; Cell Cycle Proteins; Cell Death; Cell Differentiation; Cell Line; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Phone Use; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cell Transformation, Viral; Cells, Cultured; Cellulose; Chemical Phenomena; Chemoradiotherapy; Child; Child Development; Child, Preschool; China; Chitosan; Chlorocebus aethiops; Cholecalciferol; Chromatography, Liquid; Circadian Clocks; Circadian Rhythm; Circular Dichroism; Cisplatin; Citric Acid; Clinical Competence; Clinical Laboratory Techniques; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clostridioides difficile; Clostridium Infections; Coculture Techniques; Cohort Studies; Cold Temperature; Colitis; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type XI; Color; Connective Tissue Diseases; Copper; Coronary Angiography; Coronavirus 3C Proteases; Coronavirus Infections; Cost of Illness; Counselors; COVID-19; COVID-19 Testing; Creatine Kinase; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Cryoelectron Microscopy; Cryosurgery; Crystallography, X-Ray; Cues; Cultural Competency; Cultural Diversity; Curriculum; Cyclic AMP Response Element-Binding Protein; Cyclin-Dependent Kinase Inhibitor p21; Cycloparaffins; Cysteine Endopeptidases; Cytokines; Cytoplasm; Cytoprotection; Databases, Factual; Denitrification; Deoxycytidine; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diagnosis, Differential; Diatoms; Diet; Diet, High-Fat; Dietary Exposure; Diffusion Magnetic Resonance Imaging; Diketopiperazines; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Disease Progression; Disease-Free Survival; DNA; DNA Damage; DNA Glycosylases; DNA Repair; DNA-Binding Proteins; DNA, Bacterial; DNA, Viral; Docetaxel; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Drosophila; Drosophila melanogaster; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Repositioning; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; Edema; Edible Grain; Education, Graduate; Education, Medical, Graduate; Education, Pharmacy; Ehlers-Danlos Syndrome; Electron Transport Complex III; Electron Transport Complex IV; Electronic Nicotine Delivery Systems; Emergency Service, Hospital; Empathy; Emulsions; Endothelial Cells; Endurance Training; Energy Intake; Enterovirus A, Human; Environment; Environmental Monitoring; Enzyme Assays; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Epoxide Hydrolases; Epoxy Compounds; Erythrocyte Count; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Estrogens; Etanercept; Ethiopia; Ethnicity; Ethylenes; Exanthema; Exercise; Exercise Test; Exercise Tolerance; Extracellular Matrix; Extracorporeal Membrane Oxygenation; Eye Infections, Fungal; False Negative Reactions; Fatty Acids; Fecal Microbiota Transplantation; Feces; Female; Femur Neck; Fermentation; Ferritins; Fetal Development; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibroblasts; Fibroins; Fish Proteins; Flavanones; Flavonoids; Focus Groups; Follow-Up Studies; Food Handling; Food Supply; Food, Formulated; Forced Expiratory Volume; Forests; Fractures, Bone; Fruit and Vegetable Juices; Fusobacteria; G1 Phase Cell Cycle Checkpoints; G2 Phase Cell Cycle Checkpoints; Gamma Rays; Gastrectomy; Gastrointestinal Microbiome; Gastrointestinal Stromal Tumors; Gefitinib; Gels; Gemcitabine; Gene Amplification; Gene Expression; Gene Expression Regulation; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Gene-Environment Interaction; Genotype; Germany; Glioma; Glomerular Filtration Rate; Glucagon; Glucocorticoids; Glycemic Control; Glycerol; Glycogen Synthase Kinase 3 beta; Glycolipids; Glycolysis; Goblet Cells; Gram-Negative Bacterial Infections; Granulocyte Colony-Stimulating Factor; Graphite; Greenhouse Effect; Guanidines; Haemophilus influenzae; HCT116 Cells; Health Knowledge, Attitudes, Practice; Health Personnel; Health Services Accessibility; Health Services Needs and Demand; Health Status Disparities; Healthy Volunteers; Heart Failure; Heart Rate; Heart Transplantation; Heart-Assist Devices; HEK293 Cells; Heme; Heme Oxygenase-1; Hemolysis; Hemorrhage; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Hexoses; High-Throughput Nucleotide Sequencing; Hippo Signaling Pathway; Histamine; Histamine Agonists; Histidine; Histone Deacetylase 2; HIV Infections; HIV Reverse Transcriptase; HIV-1; Homebound Persons; Homeodomain Proteins; Homosexuality, Male; Hospice and Palliative Care Nursing; HSP70 Heat-Shock Proteins; Humans; Hyaluronan Receptors; Hydrogen; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrolysis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemia; Hypoglycemic Agents; Hypoxia; Idiopathic Interstitial Pneumonias; Imaging, Three-Dimensional; Imatinib Mesylate; Immunotherapy; Implementation Science; Incidence; INDEL Mutation; Induced Pluripotent Stem Cells; Industrial Waste; Infant; Infant, Newborn; Inflammation; Inflammation Mediators; Infliximab; Infusions, Intravenous; Inhibitory Concentration 50; Injections; Insecticides; Insulin-Like Growth Factor Binding Protein 5; Insulin-Secreting Cells; Interleukin-1; Interleukin-17; Interleukin-8; Internship and Residency; Intestines; Intracellular Signaling Peptides and Proteins; Ion Transport; Iridaceae; Iridoid Glucosides; Islets of Langerhans Transplantation; Isodon; Isoflurane; Isotopes; Italy; Joint Instability; Ketamine; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Kidney Neoplasms; Kinetics; Klebsiella pneumoniae; Knee Joint; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Lactate Dehydrogenase 5; Laparoscopy; Laser Therapy; Lasers, Semiconductor; Lasers, Solid-State; Laurates; Lead; Leukocyte L1 Antigen Complex; Leukocytes, Mononuclear; Light; Lipid Peroxidation; Lipopolysaccharides; Liposomes; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Locomotion; Longitudinal Studies; Lopinavir; Lower Urinary Tract Symptoms; Lubricants; Lung; Lung Diseases, Interstitial; Lung Neoplasms; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Lymphoma, Mantle-Cell; Lysosomes; Macrophages; Male; Manganese Compounds; MAP Kinase Kinase 4; Mass Screening; Maternal Health; Medicine, Chinese Traditional; Melanoma, Experimental; Memantine; Membrane Glycoproteins; Membrane Proteins; Mesenchymal Stem Cell Transplantation; Metal Nanoparticles; Metalloendopeptidases; Metalloporphyrins; Methadone; Methane; Methicillin-Resistant Staphylococcus aureus; Mexico; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Mice, Nude; Mice, SCID; Mice, Transgenic; Microarray Analysis; Microbial Sensitivity Tests; Microbiota; Micronutrients; MicroRNAs; Microscopy, Confocal; Microsomes, Liver; Middle Aged; Milk; Milk, Human; Minority Groups; Mitochondria; Mitochondrial Membranes; Mitochondrial Proteins; Models, Animal; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Epidemiology; Molecular Structure; Molecular Weight; Multilocus Sequence Typing; Multimodal Imaging; Muscle Strength; Muscle, Skeletal; Muscular Diseases; Mutation; Mycobacterium tuberculosis; Myocardial Stunning; Myristates; NAD(P)H Dehydrogenase (Quinone); Nanocomposites; Nanogels; Nanoparticles; Nanotechnology; Naphthalenes; Nasal Cavity; National Health Programs; Necrosis; Needs Assessment; Neoadjuvant Therapy; Neonicotinoids; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm Transplantation; Neoplasms; Neoplastic Stem Cells; Netherlands; Neuroblastoma; Neuroprotective Agents; Neutrophils; NF-kappa B; NFATC Transcription Factors; Nicotiana; Nicotine; Nitrates; Nitrification; Nitrites; Nitro Compounds; Nitrogen; Nitrogen Dioxide; North Carolina; Nuclear Magnetic Resonance, Biomolecular; Nuclear Proteins; Nucleic Acid Hybridization; Nucleosomes; Nutrients; Obesity; Obesity, Morbid; Oceans and Seas; Oncogene Protein v-akt; Oncogenes; Oocytes; Open Reading Frames; Osteoclasts; Osteogenesis; Osteoporosis; Osteoporosis, Postmenopausal; Outpatients; Ovarian Neoplasms; Ovariectomy; Overweight; Oxazines; Oxidants; Oxidation-Reduction; Oxidative Stress; Oxides; Oxidoreductases; Oxygen; Oxygen Inhalation Therapy; Oxygenators, Membrane; Ozone; Paclitaxel; Paenibacillus; Pain Measurement; Palliative Care; Pancreatic Neoplasms; Pandemics; Parasympathetic Nervous System; Particulate Matter; Pasteurization; Patient Preference; Patient Satisfaction; Pediatric Obesity; Permeability; Peroxiredoxins; Peroxynitrous Acid; Pharmaceutical Services; Pharmacists; Pharmacy; Phaseolus; Phenotype; Phoeniceae; Phosphates; Phosphatidylinositol 3-Kinases; Phospholipid Transfer Proteins; Phospholipids; Phosphorus; Phosphorylation; Photoperiod; Photosynthesis; Phylogeny; Physical Endurance; Physicians; Pilot Projects; Piperidines; Pituitary Adenylate Cyclase-Activating Polypeptide; Plant Extracts; Plant Leaves; Plant Proteins; Plant Roots; Plaque, Atherosclerotic; Pneumonia; Pneumonia, Viral; Point-of-Care Testing; Polyethylene Glycols; Polymers; Polysorbates; Pore Forming Cytotoxic Proteins; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postprandial Period; Poverty; Pre-Exposure Prophylaxis; Prediabetic State; Predictive Value of Tests; Pregnancy; Pregnancy Trimester, First; Pregnancy, High-Risk; Prenatal Exposure Delayed Effects; Pressure; Prevalence; Primary Graft Dysfunction; Primary Health Care; Professional Role; Professionalism; Prognosis; Progression-Free Survival; Prolactin; Promoter Regions, Genetic; Proof of Concept Study; Proportional Hazards Models; Propylene Glycol; Prospective Studies; Prostate; Protein Binding; Protein Biosynthesis; Protein Isoforms; Protein Kinase Inhibitors; Protein Phosphatase 2; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Protein Transport; Proteoglycans; Proteome; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins c-ret; Proto-Oncogene Proteins p21(ras); Proton Pumps; Protons; Protoporphyrins; Pseudomonas aeruginosa; Pseudomonas fluorescens; Pulmonary Artery; Pulmonary Disease, Chronic Obstructive; Pulmonary Gas Exchange; Pulmonary Veins; Pyrazoles; Pyridines; Pyrimidines; Qualitative Research; Quinoxalines; Rabbits; Random Allocation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Histamine H3; Receptors, Immunologic; Receptors, Transferrin; Recombinant Proteins; Recurrence; Reference Values; Referral and Consultation; Regional Blood Flow; Registries; Regulon; Renal Insufficiency, Chronic; Reperfusion Injury; Repressor Proteins; Reproducibility of Results; Republic of Korea; Research Design; Resistance Training; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Insufficiency; Resuscitation; Retinal Dehydrogenase; Retreatment; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Ribosomal Proteins; Ribosomes; Risk Assessment; Risk Factors; Ritonavir; Rivers; RNA Interference; RNA-Seq; RNA, Messenger; RNA, Ribosomal, 16S; RNA, Small Interfering; Rosuvastatin Calcium; Rural Population; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salivary Ducts; Salivary Gland Neoplasms; San Francisco; SARS-CoV-2; Satiation; Satiety Response; Schools; Schools, Pharmacy; Seasons; Seawater; Selection, Genetic; Sequence Analysis, DNA; Serine-Threonine Kinase 3; Sewage; Sheep; Sheep, Domestic; Shock, Hemorrhagic; Signal Transduction; Silver; Silymarin; Single Photon Emission Computed Tomography Computed Tomography; Sirolimus; Sirtuin 1; Skin; Skin Neoplasms; Skin Physiological Phenomena; Sleep Initiation and Maintenance Disorders; Social Class; Social Participation; Social Support; Soil; Soil Microbiology; Solutions; Somatomedins; Soot; Specimen Handling; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spinal Fractures; Spirometry; Staphylococcus aureus; STAT1 Transcription Factor; STAT3 Transcription Factor; Streptomyces coelicolor; Stress, Psychological; Stroke; Stroke Volume; Structure-Activity Relationship; Students, Medical; Students, Pharmacy; Substance Abuse Treatment Centers; Sulfur Dioxide; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Analysis; Survival Rate; Survivin; Sweden; Swine; Swine, Miniature; Sympathetic Nervous System; T-Lymphocytes, Regulatory; Talaromyces; Tandem Mass Spectrometry; tau Proteins; Telemedicine; Telomerase; Telomere; Telomere Homeostasis; Temperature; Terminally Ill; Th1 Cells; Thiamethoxam; Thiazoles; Thiophenes; Thioredoxin Reductase 1; Thrombosis; Thulium; Thyroid Cancer, Papillary; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Time Factors; Titanium; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Transcription Factor AP-1; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transcriptome; Transforming Growth Factor beta1; Transistors, Electronic; Translational Research, Biomedical; Transplantation Tolerance; Transplantation, Homologous; Transportation; Treatment Outcome; Tretinoin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Tubulin Modulators; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Twins; Ultrasonic Therapy; Ultrasonography; Ultraviolet Rays; United States; Up-Regulation; Uranium; Urethra; Urinary Bladder; Urodynamics; Uromodulin; Uveitis; Vasoconstrictor Agents; Ventricular Function, Left; Vero Cells; Vesicular Transport Proteins; Viral Nonstructural Proteins; Visual Acuity; Vital Capacity; Vitamin D; Vitamin D Deficiency; Vitamin K 2; Vitamins; Volatilization; Voriconazole; Waiting Lists; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Whole Genome Sequencing; Wine; Wnt Signaling Pathway; Wound Healing; Wounds and Injuries; WW Domains; X-linked Nuclear Protein; X-Ray Diffraction; Xanthines; Xenograft Model Antitumor Assays; YAP-Signaling Proteins; Yogurt; Young Adult; Zebrafish; Zebrafish Proteins; Ziziphus | 2016 |
Nicotine and sensory memory in Alzheimer's disease: an event-related potential study.
Topics: Acoustic Stimulation; Aged; Alzheimer Disease; Central Nervous System Stimulants; Cholinesterase Inhibitors; Contingent Negative Variation; Cross-Over Studies; Double-Blind Method; Evoked Potentials, Auditory; Female; Humans; Male; Mental Processes; Middle Aged; Nicotine; Nicotinic Agonists; Polymethacrylic Acids; Polyvinyls; Reaction Time; Tacrine; Tobacco Use Cessation Devices | 2002 |
PET imaging of cortical 11C-nicotine binding correlates with the cognitive function of attention in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Attention; Brain; Carbon Radioisotopes; Cognition; Female; Humans; Male; Memory; Neuropsychological Tests; Nicotine; Nicotinic Agonists; Positron-Emission Tomography; Receptors, Nicotinic | 2006 |
Changes in brain 11C-nicotine binding sites in patients with mild Alzheimer's disease following rivastigmine treatment as assessed by PET.
Topics: Acetylcholinesterase; Aged; Alzheimer Disease; Brain; Butyrylcholinesterase; Carbon Radioisotopes; Cholinesterase Inhibitors; Cognition; Female; Humans; Male; Nicotine; Phenylcarbamates; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Nicotinic; Rivastigmine; Severity of Illness Index; Time Factors; Treatment Outcome | 2007 |
PET imaging of the in vivo brain acetylcholinesterase activity and nicotine binding in galantamine-treated patients with AD.
Topics: Acetylcholinesterase; Aged; Alzheimer Disease; Brain; Cholinesterase Inhibitors; Double-Blind Method; Enzyme Activation; Female; Galantamine; Humans; Male; Nicotine; Placebo Effect; Positron-Emission Tomography; Protein Binding; Tissue Distribution; Treatment Outcome | 2008 |
Tetrahydroaminoacridine (THA) in Alzheimer's disease: an assessment of attentional and mnemonic function using CANTAB.
Topics: Activities of Daily Living; Alzheimer Disease; Attention; Cross-Sectional Studies; Double-Blind Method; Drug Therapy, Computer-Assisted; Female; Humans; Male; Memory; Neuropsychological Tests; Nicotine; Physostigmine; Placebos; Reaction Time; Tacrine; Treatment Outcome | 1993 |
Increased regional cerebral glucose metabolism and semantic memory performance in Alzheimer's disease: a pilot double blind transdermal nicotine positron emission tomography study.
Topics: Alzheimer Disease; Double-Blind Method; Glucose; Humans; Memory; Nicotine | 1996 |
Four-week nicotine skin patch treatment effects on cognitive performance in Alzheimer's disease.
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Alzheimer Disease; Attention; Cognition; Female; Humans; Male; Memory; Middle Aged; Nicotine; Nicotinic Agonists; Psychomotor Performance; Treatment Outcome | 1999 |
Acute nicotine administration in Alzheimer's disease: an exploratory EEG study.
Topics: Administration, Oral; Aged; Aged, 80 and over; Alpha Rhythm; Alzheimer Disease; Beta Rhythm; Brain Mapping; Cholinesterase Inhibitors; Cross-Over Studies; Delta Rhythm; Double-Blind Method; Electroencephalography; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Pilot Projects; Polymethacrylic Acids; Polyvinyls; Tacrine; Theta Rhythm; Tobacco Use Cessation Devices; Treatment Outcome | 2000 |
Acute nicotine effects on auditory sensory memory in tacrine-treated and nontreated patients with Alzheimer's disease: an event-related potential study.
Topics: Acoustic Stimulation; Aged; Aged, 80 and over; Alzheimer Disease; Analysis of Variance; Cross-Over Studies; Double-Blind Method; Evoked Potentials, Auditory; Female; Humans; Male; Memory; Middle Aged; Nicotine; Tacrine | 2002 |
Effects of acute nicotine administration on cognitive event-related potentials in tacrine-treated and non-treated patients with Alzheimer's disease.
Topics: Administration, Oral; Aged; Aged, 80 and over; Alzheimer Disease; Cognition; Double-Blind Method; Event-Related Potentials, P300; Evoked Potentials, Auditory; Evoked Potentials, Visual; Female; Humans; Male; Middle Aged; Nicotine; Nootropic Agents; Tacrine | 2002 |
Effects of transdermal nicotine on learning, memory, verbal fluency, concentration, and general health in a healthy sample at risk for dementia.
Topics: Adult; Aged; Alzheimer Disease; Attention; Cohort Studies; Dose-Response Relationship, Drug; Female; Genetic Predisposition to Disease; Health Status; Humans; Learning; Long-Term Care; Male; Memory; Middle Aged; Neuropsychological Tests; Nicotine; Psychomotor Performance; Reaction Time; Risk; Verbal Behavior | 2001 |
Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in Alzheimer's disease.
Topics: Adult; Aged; Alzheimer Disease; Analysis of Variance; Attention; Female; Humans; Injections, Subcutaneous; Male; Memory, Short-Term; Mental Processes; Middle Aged; Neuropsychological Tests; Nicotine; Reaction Time; Smoking | 1992 |
Intravenous nicotine in Alzheimer's disease: a pilot study.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Behavior; Blood Pressure; Cognition; Female; Humans; Injections, Intravenous; Male; Middle Aged; Nicotine; Pilot Projects; Pulse | 1988 |
110 other study(ies) available for nicotine and Alzheimer Disease
| Article | Year |
|---|---|
Evaluation of nicotine and cotinine analogs as potential neuroprotective agents for Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Cell Survival; Cells, Cultured; Cotinine; Humans; Neurons; Neuroprotective Agents; Nicotine; Peptide Fragments; Rats; Receptors, N-Methyl-D-Aspartate | 2014 |
Age- and Nicotine-Associated Gene Expression Changes in the Hippocampus of APP/PS1 Mice.
Topics: Aging; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Calcium Channels; Cell Respiration; Cellular Senescence; Hippocampus; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Nicotine; Phosphatidylinositol 3-Kinases; Presenilin-1; Transcriptome | 2019 |
Differential blockade by huperzine A and donepezil of sympathetic nicotinic acetylcholine receptor-mediated nitrergic neurogenic dilations in porcine basilar arteries.
Topics: Alkaloids; Alzheimer Disease; Animals; Basilar Artery; Brain Stem; Calcium; Cholinesterase Inhibitors; Cognitive Dysfunction; Donepezil; Dose-Response Relationship, Drug; Humans; Models, Animal; Nicotine; Nitrergic Neurons; Oocytes; Patch-Clamp Techniques; Rats; Receptors, Nicotinic; Sesquiterpenes; Swine; Synaptic Transmission; Vasodilation; Xenopus laevis | 2020 |
Nicotine prevents in vivo Aβ toxicity in Caenorhabditis elegans via SKN-1.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Caenorhabditis elegans; Caenorhabditis elegans Proteins; DNA-Binding Proteins; Nicotine; Nicotinic Agonists; Reactive Oxygen Species; Transcription Factors | 2021 |
Network pharmacological evaluation of
Topics: Alzheimer Disease; Humans; Molecular Docking Simulation; Neurodegenerative Diseases; Nicotine; Phytochemicals; Plant Extracts; Withania | 2022 |
Chronic nicotine attenuates behavioral and synaptic plasticity impairments in a streptozotocin model of Alzheimer's disease.
Topics: Alzheimer Disease; Animals; CA1 Region, Hippocampal; Cell Count; Disease Models, Animal; Locomotion; Long-Term Potentiation; Male; Neurons; Nicotine; Prefrontal Cortex; Rats, Wistar; Recognition, Psychology; Streptozocin; Synaptic Potentials | 2017 |
Alzheimer's disease and cigarette smoke components: effects of nicotine, PAHs, and Cd(II), Cr(III), Pb(II), Pb(IV) ions on amyloid-β peptide aggregation.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Cadmium; Chromium; Cigarette Smoking; Humans; Ions; Lead; Nicotine; Peptide Fragments; Plaque, Amyloid; Polycyclic Aromatic Hydrocarbons; Risk Factors; Smoking | 2017 |
Nicotine and methyl vinyl ketone, major components of cigarette smoke extracts, increase protective amyloid-β peptides in cells harboring amyloid-β precursor protein.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Butanones; Cells, Cultured; Cigarette Smoking; Depression, Chemical; Humans; Nicotine; Tobacco Products | 2018 |
Beta-amyloid peptides undergo regulated co-secretion with neuropeptide and catecholamine neurotransmitters.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Animals; Catecholamines; Cattle; Cells, Cultured; Chromaffin Cells; Colforsin; Cyclic AMP; Dopamine; Enkephalins; Epinephrine; Galanin; Ganglionic Stimulants; Humans; Neuroblastoma; Neurons; Neuropeptide Y; Neuropeptides; Neurotransmitter Agents; Nicotine; Norepinephrine; Peptide Fragments; Secretory Vesicles | 2013 |
Nicotine prevents synaptic impairment induced by amyloid-β oligomers through α7-nicotinic acetylcholine receptor activation.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Androstadienes; Animals; beta Catenin; Bungarotoxins; Cells, Cultured; Dendrites; Disks Large Homolog 4 Protein; Hippocampus; Intracellular Signaling Peptides and Proteins; Maze Learning; Membrane Proteins; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neurites; Neurons; Nicotine; Patch-Clamp Techniques; Peptide Fragments; Phosphatidylinositol 3-Kinases; Plaque, Amyloid; Presenilin-1; Presynaptic Terminals; Rats; Rats, Sprague-Dawley; Recombinant Fusion Proteins; Signal Transduction; Synapsins; Wnt Proteins; Wnt Signaling Pathway; Wortmannin | 2013 |
³H-deprenyl and ³H-PIB autoradiography show different laminar distributions of astroglia and fibrillar β-amyloid in Alzheimer brain.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Astrocytes; Autoradiography; Benzothiazoles; Bungarotoxins; Cerebral Cortex; Female; Hippocampus; Humans; Immunohistochemistry; Isoquinolines; Isotope Labeling; Male; Nicotine; Parasympathetic Nervous System; Radionuclide Imaging; Receptors, Nicotinic; Selegiline; Synaptic Transmission; Thiazoles | 2013 |
High-energy compounds mobilize intracellular Ca2+ and activate calpain in cultured cells: is calpain an energy-dependent protease?
Topics: Acetyl Coenzyme A; Adenosine Triphosphate; Alzheimer Disease; Calcium; Calpain; Cell Line, Tumor; Chelating Agents; Cysteine Proteinase Inhibitors; Dipeptides; Egtazic Acid; Extracellular Space; Glutamic Acid; Humans; Intracellular Space; Nicotine; Nicotinic Agonists; Phosphocreatine; Phosphoenolpyruvate; Rotenone; Uncoupling Agents | 2014 |
Targeted studies on the interaction of nicotine and morin molecules with amyloid β-protein.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Binding Sites; Flavonoids; Humans; Hydrophobic and Hydrophilic Interactions; Kinetics; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Structure; Nicotine; Peptide Fragments; Protein Binding; Protein Conformation; Protein Structure, Secondary; Protein Structure, Tertiary | 2014 |
Enhanced behavioral response by decreasing brain oxidative stress to 6-hydroxy-l-nicotine in Alzheimer's disease rat model.
Topics: Alzheimer Disease; Animals; Hippocampus; Lipid Peroxidation; Male; Maze Learning; Neuroprotective Agents; Nicotine; Oxidative Stress; Rats, Wistar; Spatial Memory | 2015 |
Low dose nicotine attenuates Aβ neurotoxicity through activation early growth response gene 1 pathway.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Apoptosis; Blotting, Western; Cell Proliferation; Cells, Cultured; Dose-Response Relationship, Drug; Early Growth Response Protein 1; Fluorescent Antibody Technique; Gene Expression Regulation; Hippocampus; Humans; Immunoenzyme Techniques; Male; Mice, Inbred C57BL; Neuroblastoma; Neurons; Nicotine; PC12 Cells; Rats; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction | 2015 |
Comparison of Regional Brain Perfusion Levels in Chronically Smoking and Non-Smoking Adults.
Topics: Adult; Alzheimer Disease; Brain; Cerebrovascular Circulation; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nicotine; Smoking; Spin Labels; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2015 |
Protective effect of nicotine on the cultured rat basal forebrain neurons damaged by β-Amyloid (Aβ)25-35 protein cytotoxicity.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Basal Forebrain; Neurons; Nicotine; Peptide Fragments; Rats | 2015 |
Noninvasive evaluation of nicotinic acetylcholine receptor availability in mouse brain using single-photon emission computed tomography with [(123)I]5IA.
Topics: Alzheimer Disease; Animals; Autoradiography; Azetidines; Brain; Male; Mice; Mice, Inbred C57BL; Nicotine; Pyridines; Receptors, Nicotinic; Tissue Distribution; Tomography, Emission-Computed, Single-Photon | 2016 |
Functional Characterization of Acetylcholine Receptors Expressed in Human Neurons Differentiated from Hippocampal Neural Stem/Progenitor Cells.
Topics: Acetylcholine; Alzheimer Disease; Cell Differentiation; Drug Delivery Systems; Gene Expression Regulation, Developmental; Hippocampus; Humans; Muscarine; Neural Stem Cells; Neurons; Nicotine; Patch-Clamp Techniques; Receptor, Muscarinic M1; Receptor, Muscarinic M3; Receptors, Cholinergic; Receptors, Nicotinic; Stem Cells; Synaptic Transmission | 2016 |
Alpha7 nicotinic acetylcholine receptor is required for amyloid pathology in brain endothelial cells induced by Glycoprotein 120, methamphetamine and nicotine.
Topics: Aconitine; alpha7 Nicotinic Acetylcholine Receptor; Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Animals; Biomarkers; Blood-Brain Barrier; Brain; Cell Movement; Cellular Senescence; Endothelial Cells; HIV Envelope Protein gp120; HL-60 Cells; Humans; Methamphetamine; Mice, Inbred C57BL; Monocytes; Nicotine; Protein Transport; Receptor for Advanced Glycation End Products; S100 Proteins; Time Factors | 2017 |
Drugs of abuse that mediate advanced glycation end product formation: a chemical link to disease pathology.
Topics: Alzheimer Disease; Atherosclerosis; Diabetes Mellitus; Disease; Glycation End Products, Advanced; Humans; Macular Degeneration; Methamphetamine; Molecular Structure; Neoplasms; Nicotine | 2009 |
Chronic nicotine restores normal Aβ levels and prevents short-term memory and E-LTP impairment in Aβ rat model of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; Aspartic Acid Endopeptidases; Brain-Derived Neurotrophic Factor; CA1 Region, Hippocampal; Disease Models, Animal; Ganglionic Stimulants; Learning; Long-Term Potentiation; Male; Maze Learning; Memory Disorders; Memory, Short-Term; Nicotine; Rats; Rats, Wistar; Receptors, Nicotinic; Synaptic Transmission; Up-Regulation | 2011 |
Association constants of pyridine and piperidine alkaloids to amyloid beta peptide determined by electrochemical impedance spectroscopy.
Topics: Alkaloids; Alzheimer Disease; Amyloid beta-Peptides; Binding, Competitive; Blood-Brain Barrier; Brain; Brain Chemistry; Electric Impedance; Electrochemistry; Electrodes; Humans; Microscopy; Nicotine; Peptide Fragments; Piperidines; Pyridines | 2010 |
Nicotine exacerbates tau phosphorylation and cognitive impairment induced by amyloid-beta 25-35 in rats.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Blotting, Western; Cognition Disorders; Disease Models, Animal; Hippocampus; Immunohistochemistry; Male; Maze Learning; Nicotine; Peptide Fragments; Phosphorylation; Rats; Rats, Sprague-Dawley; tau Proteins; Time Factors | 2010 |
Intensification of long-term memory deficit by chronic stress and prevention by nicotine in a rat model of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid; Animals; Brain-Derived Neurotrophic Factor; Calcium-Calmodulin-Dependent Protein Kinase Type 4; Cyclic AMP Response Element-Binding Protein; Ganglionic Stimulants; Learning; Male; Memory Disorders; Memory, Long-Term; Neuropsychological Tests; Nicotine; Rats; Rats, Wistar; Stress, Physiological | 2010 |
In silico theoretical molecular modeling for Alzheimer's disease: the nicotine-curcumin paradigm in neuroprotection and neurotherapy.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Computational Biology; Curcumin; Humans; Neuroprotective Agents; Nicotine | 2011 |
Elevation of BACE in an Aβ rat model of Alzheimer's disease: exacerbation by chronic stress and prevention by nicotine.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Animals; Aspartic Acid Endopeptidases; Chronic Disease; Disease Models, Animal; Male; Nicotine; Rats; Rats, Wistar; Stress, Psychological | 2012 |
Chronic psychosocial stress exacerbates impairment of synaptic plasticity in β-amyloid rat model of Alzheimer's disease: prevention by nicotine.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Blotting, Western; Disease Models, Animal; Male; Neuronal Plasticity; Nicotine; Nicotinic Agonists; Rats; Rats, Wistar; Stress, Psychological | 2011 |
Different β-amyloid oligomer assemblies in Alzheimer brains correlate with age of disease onset and impaired cholinergic activity.
Topics: Age Factors; Age of Onset; Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Apolipoproteins E; Benzothiazoles; Brain; Cholinergic Agents; Enzyme-Linked Immunosorbent Assay; Female; Genotype; Humans; Immunoprecipitation; Male; Middle Aged; Nicotine; Nicotinic Agonists; Peptide Fragments; Postmortem Changes; Protein Binding; Statistics as Topic; Thiazoles; Tritium | 2012 |
Nicotine evoked improvement in learning and memory is mediated through NPY Y1 receptors in rat model of Alzheimer's disease.
Topics: Alzheimer Disease; Amygdala; Analysis of Variance; Animals; Arcuate Nucleus of Hypothalamus; Arginine; Colchicine; Dentate Gyrus; Disease Models, Animal; Escape Reaction; Learning; Male; Maze Learning; Memory; Neuropeptide Y; Nicotine; Nicotinic Agonists; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Septal Nuclei | 2012 |
Smoking, nicotine and dementia.
Topics: Alzheimer Disease; Dementia; Humans; Nicotine; Nicotinic Agonists; Phytotherapy; Plant Extracts; Smoking | 2012 |
Encapsulated cell biodelivery of nerve growth factor to the Basal forebrain in patients with Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Autopsy; Biopsy; Cell Line; Cerebral Cortex; Cognition; Dose-Response Relationship, Drug; Electroencephalography; Feasibility Studies; Female; Humans; Infusion Pumps, Implantable; Magnetic Resonance Imaging; Male; Middle Aged; Nerve Growth Factors; Neuropsychological Tests; Neurosurgical Procedures; Nicotine; Positron-Emission Tomography; Prosencephalon; Receptors, Nicotinic; Treatment Outcome | 2012 |
Evidence supporting the role of calpain in the α-processing of amyloid-β precursor protein.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Biotinylation; Calpain; Cell Membrane; Genetic Vectors; Glutamic Acid; HEK293 Cells; Humans; Nicotine; Phorbol 12,13-Dibutyrate; Substrate Specificity | 2012 |
Nicotine promotes survival of cells expressing amyloid precursor protein and presenilin: implication for Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Cell Line, Tumor; Cell Survival; Mecamylamine; Mice; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Presenilins | 2013 |
New nicotinic analogue ZY-1 enhances cognitive functions in a transgenic mice model of Alzheimer's disease.
Topics: Alkaloids; Alzheimer Disease; Animals; Cell Line; Escape Reaction; Maze Learning; Mice; Mice, Transgenic; Nicotine; Nicotinic Agonists; Radioligand Assay; Reaction Time; Receptors, Nicotinic; Sesquiterpenes | 2013 |
Cholinergic receptor activity after quinolinic acid caused cerebral injury in rats.
Topics: Alzheimer Disease; Animals; Brain; Choline O-Acetyltransferase; Disease Models, Animal; Learning; Male; Memory; Nicotine; Quinolinic Acid; Quinuclidinyl Benzilate; Rats; Rats, Wistar; Receptors, Cholinergic | 2002 |
Nicotine breaks down preformed Alzheimer's beta-amyloid fibrils in vitro.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Culture Techniques; Dose-Response Relationship, Drug; Humans; Microscopy, Polarization; Neurofibrillary Tangles; Neurons; Nicotine; Pyridines; Pyrrolidines; Spectrometry, Fluorescence | 2002 |
Nicotine lowers the secretion of the Alzheimer's amyloid beta-protein precursor that contains amyloid beta-peptide in rat.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Ganglionic Stimulants; Male; Neuroprotective Agents; Nicotine; Rats; Rats, Inbred F344; Receptors, Muscarinic; Receptors, Nicotinic | 2002 |
Nicotine enhances the depressive actions of A beta 1-40 on long-term potentiation in the rat hippocampal CA1 region in vivo.
Topics: Aconitine; Alzheimer Disease; Amyloid beta-Peptides; Animals; Electrophysiology; Hippocampus; Injections, Intraventricular; Long-Term Potentiation; Male; Neuronal Plasticity; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Peptide Fragments; Rats; Rats, Wistar; Receptors, Nicotinic | 2003 |
Glycation of the amyloid beta-protein by a nicotine metabolite: a fortuitous chemical dynamic between smoking and Alzheimer's disease.
Topics: Alzheimer Disease; Amino Acid Motifs; Amino Acid Sequence; Amyloid beta-Peptides; Glucose; Glycosylation; Humans; Lysine; Molecular Sequence Data; Neuroprotective Agents; Nicotine; Nuclear Magnetic Resonance, Biomolecular; Oxidation-Reduction; Peptide Fragments; Smoking; Solubility | 2003 |
Cysteine proteases are the major beta-secretase in the regulated secretory pathway that provides most of the beta-amyloid in Alzheimer's disease: role of BACE 1 in the constitutive secretory pathway.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; Aspartic Acid Endopeptidases; Cells, Cultured; Chromaffin Cells; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Dithiothreitol; Endopeptidases; Extracellular Space; Glutathione; Leucine; Mice; Mice, Knockout; Mutation; Neurons; Nicotine; Nicotinic Agonists; Peptide Fragments; Potassium Chloride; Secretory Vesicles; Substrate Specificity; Time Factors | 2003 |
Reduced levels of Abeta 40 and Abeta 42 in brains of smoking controls and Alzheimer's patients.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Binding Sites; Brain; Bridged Bicyclo Compounds, Heterocyclic; Bungarotoxins; Cystine; Down-Regulation; Humans; Iodine Radioisotopes; Middle Aged; Nicotine; Nicotinic Agonists; Peptide Fragments; Pyridines; Radioligand Assay; Receptors, Nicotinic; Smoking; Tritium | 2004 |
Two-site binding of beta-cyclodextrin to the Alzheimer Abeta(1-40) peptide measured with combined PFG-NMR diffusion and induced chemical shifts.
Topics: Alzheimer Disease; Amyloid beta-Peptides; beta-Cyclodextrins; Binding Sites; Cyclodextrins; Humans; Models, Molecular; Nicotine; Nicotinic Agonists; Nuclear Magnetic Resonance, Biomolecular; Peptide Fragments; Protein Binding; Protein Structure, Tertiary | 2004 |
Repeated nicotine exposure in rats: effects on memory function, cholinergic markers and nerve growth factor.
Topics: Acetylcholine; Alzheimer Disease; Animals; Binding, Competitive; Biomarkers; Brain; Choline O-Acetyltransferase; Cholinergic Fibers; Dose-Response Relationship, Drug; Male; Maze Learning; Membrane Transport Proteins; Memory; Nerve Growth Factor; Nicotine; Radioligand Assay; Rats; Rats, Wistar; Receptors, Nerve Growth Factor; Receptors, Nicotinic; Up-Regulation; Vesicular Acetylcholine Transport Proteins | 2005 |
Chronic nicotine administration exacerbates tau pathology in a transgenic model of Alzheimer's disease.
Topics: Age Factors; alpha7 Nicotinic Acetylcholine Receptor; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Calcium; Disease Models, Animal; Mice; Mice, Transgenic; Nicotine; Phosphorylation; Receptors, Nicotinic; tau Proteins | 2005 |
Nicotine-induced enhancement of synaptic plasticity at CA3-CA1 synapses requires GABAergic interneurons in adult anti-NGF mice.
Topics: Alzheimer Disease; Animals; Disease Models, Animal; Excitatory Postsynaptic Potentials; Female; gamma-Aminobutyric Acid; Ganglionic Stimulants; Hippocampus; Interneurons; Long-Term Potentiation; Male; Mice; Mice, Transgenic; Nerve Growth Factor; Neuronal Plasticity; Nicotine; Receptors, N-Methyl-D-Aspartate; Receptors, Nicotinic; Synapses; Synaptic Transmission | 2006 |
Dissecting the signaling pathway of nicotine-mediated neuroprotection in a mouse Alzheimer disease model.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Base Sequence; Cell Line; DNA Primers; Enzyme Activation; Mice; Mice, Transgenic; Mitogen-Activated Protein Kinases; Neuroprotective Agents; NF-kappa B; Nicotine; Nitric Oxide; Nitric Oxide Synthase Type II; Receptors, Nicotinic; RNA Interference; Signal Transduction | 2007 |
Antiamnestic effect of alpha7-nicotinic receptor agonist RJR-2403 in middle-aged ovariectomized rats with Alzheimer type dementia.
Topics: Acetylcholine; Alzheimer Disease; Amnesia; Animals; Avoidance Learning; Drug Therapy, Combination; Estradiol; Female; Mecamylamine; Nicotine; Nicotinic Agonists; Ovariectomy; Rats; Rats, Wistar; Receptors, Nicotinic | 2006 |
FTIR microspectroscopic analysis of the effects of certain drugs on oxidative stress and brain protein structure.
Topics: Alzheimer Disease; Amphetamine; Amyloid beta-Peptides; Animals; Brain; Brain Chemistry; Central Nervous System Stimulants; Ganglionic Stimulants; Humans; Lipid Peroxidation; Male; Nicotine; Oxidative Stress; Protein Structure, Secondary; Rats; Rats, Sprague-Dawley; Spectroscopy, Fourier Transform Infrared | 2008 |
Nicotine leads to improvements in behavioral impairment and an increase in the nicotine acetylcholine receptor in transgenic mice.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Behavior, Animal; Female; Humans; Male; Maze Learning; Mice; Mice, Transgenic; Molecular Structure; Nicotine; Nicotinic Agonists; Phosphopyruvate Hydratase; Receptors, Nicotinic | 2008 |
Autoradiographic distribution of nicotine receptors in rat brain.
Topics: Alzheimer Disease; Animals; Autoradiography; Brain; Bungarotoxins; Humans; Male; Nicotine; Rats; Rats, Inbred Strains; Receptors, Nicotinic; Synaptic Transmission | 1984 |
Enhanced behavioral response to nicotine in an animal model of Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Dextroamphetamine; Disease Models, Animal; Humans; Kainic Acid; Male; Motor Activity; Nicotine; Rats | 1983 |
Effects of tetrahydroaminoacridine and nicotine in nucleus basalis and serotonin-lesioned rats.
Topics: Alzheimer Disease; Analysis of Variance; Animals; Avoidance Learning; Basal Ganglia; Cerebral Cortex; Cholinesterase Inhibitors; Fenclonine; Male; Maze Learning; Nicotine; Nicotinic Agonists; Rats; Rats, Wistar; Serotonin; Tacrine | 1995 |
Acetylcholine receptors: too many channels, too few functions.
Topics: Alzheimer Disease; Animals; Biological Evolution; Brain; Brain Chemistry; Bungarotoxins; Ganglia, Autonomic; Humans; Muscle, Skeletal; Neurotransmitter Agents; Nicotine; Nicotinic Agonists; Presynaptic Terminals; Receptors, Nicotinic; Synaptic Transmission | 1995 |
Lesion with the neurotoxin AF64A alters hippocampal cholinergic receptor function.
Topics: Acetylcholine; Alzheimer Disease; Animals; Aziridines; Choline; Disease Models, Animal; Electric Stimulation; Hippocampus; In Vitro Techniques; Injections, Intraventricular; Male; Neurotoxins; Nicotine; Oxotremorine; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Cholinergic; Stimulation, Chemical | 1995 |
Kinetic analysis of regional (S)(-)11C-nicotine binding in normal and Alzheimer brains--in vivo assessment using positron emission tomography.
Topics: Aged; Alzheimer Disease; Blood Flow Velocity; Brain; Female; Frontal Lobe; Hippocampus; Humans; Male; Middle Aged; Nicotine; Receptors, Nicotinic; Reference Values; Regional Blood Flow; Synaptic Transmission; Temporal Lobe; Tomography, Emission-Computed | 1995 |
(S)-3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: II. In vivo characterization.
Topics: Alzheimer Disease; Animals; Anti-Anxiety Agents; Anticonvulsants; Avoidance Learning; Behavior, Animal; Body Temperature; Brain; Cerebrovascular Circulation; Cognition; Electroencephalography; Isoxazoles; Male; Mice; Mice, Inbred Strains; Motor Activity; Nicotine; Nociceptors; Pyrrolidines; Rats; Rats, Wistar; Receptors, Cholinergic; Seizures; Vomiting | 1994 |
Nicotine effects on the regulation of amyloid precursor protein splicing, neurotrophin and glucose transporter RNA levels in aged rats.
Topics: Aging; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Base Sequence; Brain-Derived Neurotrophic Factor; Disease Susceptibility; Gene Expression Regulation; Genes, fos; Male; Molecular Sequence Data; Monosaccharide Transport Proteins; Nerve Growth Factors; Nerve Tissue Proteins; Nicotine; Polymerase Chain Reaction; Rats; Rats, Wistar; RNA Splicing; RNA, Messenger | 1994 |
Effect of long-term treatment with tacrine (THA) in Alzheimer's disease as visualized by PET.
Topics: Alzheimer Disease; Cerebrovascular Circulation; Female; Frontal Lobe; Glucose; Humans; Male; Nicotine; Receptors, Muscarinic; Receptors, Nicotinic; Tacrine; Temporal Lobe; Tomography, Emission-Computed; Treatment Outcome | 1993 |
Alzheimer disease, attention, and the cholinergic system.
Topics: Alzheimer Disease; Attention; Cholinergic Agents; Humans; Nicotine; Research Design; Tacrine | 1995 |
Potential treatment of Alzheimer disease using cholinergic channel activators (ChCAs) with cognitive enhancement, anxiolytic-like, and cytoprotective properties.
Topics: Alzheimer Disease; Animals; Anti-Anxiety Agents; Avoidance Learning; Cognition; Dose-Response Relationship, Drug; Isoxazoles; Nicotine; Nicotinic Agonists; Pyrrolidines; Rats | 1995 |
Epibatidine and ABT 418 reveal selective losses of alpha 4 beta 2 nicotinic receptors in Alzheimer brains.
Topics: Aged; Aged, 80 and over; Alkaloids; Alzheimer Disease; Animals; Anti-Anxiety Agents; Azocines; Binding, Competitive; Bridged Bicyclo Compounds, Heterocyclic; Cells, Cultured; Humans; Isoxazoles; Kinetics; Mice; Nicotine; Nicotinic Agonists; Pyridines; Pyrrolidines; Quinolizines; Receptors, Nicotinic; Temporal Lobe; Transfection | 1995 |
Amnesia induced in mice by centrally administered beta-amyloid peptides involves cholinergic dysfunction.
Topics: Acetylcholine; Alzheimer Disease; Amnesia; Amyloid beta-Peptides; Animals; Avoidance Learning; Cholinesterase Inhibitors; Injections, Intraventricular; Male; Maze Learning; Mice; Nicotine; Peptide Fragments; Tacrine | 1996 |
Nicotine inhibits amyloid formation by the beta-peptide.
Topics: Alzheimer Disease; Amino Acid Sequence; Amyloid beta-Peptides; Amyloidosis; Chemical Precipitation; Circular Dichroism; Cotinine; Humans; Magnetic Resonance Spectroscopy; Molecular Sequence Data; Molecular Structure; Nicotine; Peptide Fragments; Protein Binding; Protein Structure, Secondary; Pyridines; Pyrrolidines; Spectrophotometry, Ultraviolet | 1996 |
Stimulation of alpha4beta2 nicotinic acetylcholine receptors inhibits beta-amyloid toxicity.
Topics: Alkaloids; Alzheimer Disease; Amyloid beta-Peptides; Animals; Azocines; Bungarotoxins; Cells, Cultured; Cerebral Cortex; Dihydro-beta-Erythroidine; Fetus; Neurons; Neuroprotective Agents; Nicotine; Nicotinic Agonists; Quinolizines; Rats; Receptors, Nicotinic | 1998 |
D-cycloserine, a partial NMDA receptor-associated glycine-B site agonist, enhances reversal learning, but a cholinesterase inhibitor and nicotine has no effect.
Topics: Alzheimer Disease; Animals; Antimetabolites; Binding Sites; Cholinesterase Inhibitors; Conditioning, Psychological; Cycloserine; Denervation; Glycine; Maze Learning; Nicotine; Nicotinic Agonists; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Reversal Learning; Septal Nuclei; Tacrine | 1998 |
New studies illuminate brain disorders.
Topics: Alzheimer Disease; Animals; Chlamydia Infections; Chlamydophila pneumoniae; Disease Models, Animal; Dogs; Humans; Memory; Narcolepsy; Nicotine; Receptors, Nicotinic | 1999 |
Neuronal nicotinic receptor deficits in Alzheimer patients with the Swedish amyloid precursor protein 670/671 mutation.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Protein Precursor; Apolipoproteins E; Binding, Competitive; Brain; Bridged Bicyclo Compounds, Heterocyclic; Female; Genotype; Humans; Kinetics; Male; Middle Aged; Mutation; Neurofibrillary Tangles; Neurons; Nicotine; Nicotinic Agonists; Pyridines; Receptors, Nicotinic; Sweden | 1999 |
Regional distribution of nicotinic receptor subunit mRNAs in human brain: comparison between Alzheimer and normal brain.
Topics: Aged; Aged, 80 and over; alpha7 Nicotinic Acetylcholine Receptor; Alzheimer Disease; Binding, Competitive; Brain Chemistry; Bridged Bicyclo Compounds, Heterocyclic; Bungarotoxins; Cerebellum; Female; Hippocampus; Humans; Iodine Radioisotopes; Male; Middle Aged; Nicotine; Nicotinic Agonists; Peptidylprolyl Isomerase; Pyridines; Receptors, Nicotinic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Temporal Lobe; Tritium | 1999 |
In vitro and in vivo studies investigating possible antioxidant actions of nicotine: relevance to Parkinson's and Alzheimer's diseases.
Topics: Alzheimer Disease; Animals; Antioxidants; Brain; Brain Chemistry; Chromatography, Liquid; Cognition; In Vitro Techniques; Iron; Male; Memory; Nicotine; Parkinson Disease; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Thiobarbituric Acid Reactive Substances | 1999 |
Autoradiographic comparison of [3H](-)nicotine, [3H]cytisine and [3H]epibatidine binding in relation to vesicular acetylcholine transport sites in the temporal cortex in Alzheimer's disease.
Topics: Acetylcholine; Age Factors; Aged; Aged, 80 and over; Alkaloids; Alzheimer Disease; Autoradiography; Azocines; Bridged Bicyclo Compounds, Heterocyclic; Carrier Proteins; Female; Humans; Male; Membrane Transport Proteins; Middle Aged; Nicotine; Piperidines; Pyridines; Quinolizines; Reference Values; Temporal Lobe; Tritium; Vesicular Acetylcholine Transport Proteins; Vesicular Transport Proteins | 1999 |
Development of nicotinic drug therapy for cognitive disorders.
Topics: Adult; Alzheimer Disease; Animals; Attention; Attention Deficit Disorder with Hyperactivity; Cognition Disorders; Disease Models, Animal; Drug Design; Humans; Learning; Memory; Nicotine; Nicotinic Agonists; Rats; Schizophrenia; Smoking | 2000 |
Nicotinic receptor subtypes in human brain ageing, Alzheimer and Lewy body diseases.
Topics: Acetylcholinesterase; Aging; alpha7 Nicotinic Acetylcholine Receptor; Alzheimer Disease; Analysis of Variance; Animals; Brain; Humans; Lewy Body Disease; Mice; Mice, Transgenic; Nicotine; Receptors, Nicotinic; Smoking | 2000 |
Smoking and the brain.
Topics: Alzheimer Disease; Dementia; Humans; Nicotine; Nicotinic Antagonists; Risk Factors; Smoking | 2000 |
Nicotine binding in human striatum: elevation in schizophrenia and reductions in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease and in relation to neuroleptic medication.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antipsychotic Agents; Cognition Disorders; Female; Humans; Lewy Body Disease; Male; Middle Aged; Neostriatum; Neurodegenerative Diseases; Nicotiana; Nicotine; Parkinson Disease; Plants, Toxic; Radioligand Assay; Receptors, Dopamine D2; Receptors, Nicotinic; Schizophrenia; Sex Factors; Synapses; Tritium | 2000 |
Impaired cholinergic function in cell lines derived from the cerebral cortex of normal and trisomy 16 mice.
Topics: Acetylcholine; Alzheimer Disease; Animals; Cell Line; Cerebral Cortex; Choline; Choline O-Acetyltransferase; Disease Models, Animal; Down Syndrome; Female; Male; Membrane Potentials; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Neurons; Nicotine; Nicotinic Agonists; Pregnancy; Receptors, Cholinergic; Trisomy; Tritium | 2000 |
Health news. The sleeper syndrome.
Topics: Alzheimer Disease; Cacao; Humans; Hygiene; Isoxazoles; Margarine; Nicotine; Parkinson Disease; Pyrrolidines; Superoxides | 2001 |
Effects of nicotine on APP secretion and Abeta- or CT(105)-induced toxicity.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Cell Survival; Dose-Response Relationship, Drug; Humans; Neuroprotective Agents; Nicotine; PC12 Cells; Peptide Fragments; Rats; Receptors, Nicotinic | 2001 |
Nicotine and amyloid formation.
Topics: Alzheimer Disease; Amino Acid Sequence; Amyloid beta-Peptides; Brain; Humans; Magnetic Resonance Spectroscopy; Nicotine; Peptide Fragments; Protein Conformation; Receptors, Nicotinic; Structure-Activity Relationship | 2001 |
Neuronal nicotinic receptors: no smoke without fire!
Topics: Alzheimer Disease; Cognition; Humans; Memory; Neurons; Nicotine; Receptors, Nicotinic; Schizophrenia; Smoking; Synapses | 2001 |
Beta-amyloid activates the mitogen-activated protein kinase cascade via hippocampal alpha7 nicotinic acetylcholine receptors: In vitro and in vivo mechanisms related to Alzheimer's disease.
Topics: Aging; alpha7 Nicotinic Acetylcholine Receptor; Alzheimer Disease; Amyloid beta-Peptides; Animals; Cells, Cultured; Chronic Disease; Cyclic AMP Response Element-Binding Protein; Disease Models, Animal; Enzyme Activation; Enzyme Activators; Heterozygote; Hippocampus; In Vitro Techniques; MAP Kinase Signaling System; Maze Learning; Mice; Mice, Transgenic; Mitogen-Activated Protein Kinase 1; Nicotine; Nicotinic Antagonists; Peptide Fragments; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Up-Regulation | 2001 |
Transdermal nicotine for agitation in dementia.
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Alzheimer Disease; Female; Humans; Nicotine; Psychomotor Agitation | 2001 |
Chronic inhibition of alpha4beta2 nicotinic receptors in the ventral hippocampus of rats: impacts on memory and nicotine response.
Topics: Alzheimer Disease; Animals; Cognition Disorders; Dihydro-beta-Erythroidine; Female; Hippocampus; Memory; Nicotine; Nicotinic Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Time Factors | 2002 |
Rethinking nicotine.
Topics: Alzheimer Disease; Animals; Arteriosclerosis; Carcinoma, Lewis Lung; Disease Models, Animal; Ganglionic Stimulants; Mice; Neovascularization, Pathologic; Nicotine | 2001 |
Effects of repeated administration of (-)-nicotine on AF64A-induced learning and memory impairment in rats.
Topics: Acetylcholine; Alzheimer Disease; Animals; Avoidance Learning; Aziridines; Choline; Choline O-Acetyltransferase; Cholinergic Fibers; Hippocampus; Male; Maze Learning; Memory; Memory Disorders; Motor Activity; Neuromuscular Blocking Agents; Neuroprotective Agents; Nicotine; Rats; Rats, Sprague-Dawley | 2002 |
Are acetylcholine-induced acetyl groups driving fuel cells in the systems of transducin, t and G proteins?
Topics: Acetylation; Acetylcholine; Adenine Nucleotides; Alzheimer Disease; Energy Metabolism; Ethanol; GTP-Binding Proteins; Guanine Nucleotides; Humans; Models, Biological; Nicotine; tau Proteins; Transducin | 2002 |
Chronic nicotine treatment reduces beta-amyloidosis in the brain of a mouse model of Alzheimer's disease (APPsw).
Topics: Administration, Oral; Alzheimer Disease; Amyloid beta-Peptides; Animals; Astrocytes; Brain Chemistry; Cell Count; Cerebral Cortex; Disease Models, Animal; Disease Progression; Drug Administration Schedule; Female; Glial Fibrillary Acidic Protein; Hippocampus; Humans; Immunohistochemistry; Male; Mice; Mice, Transgenic; Nicotine; Olfactory Pathways; Peptide Fragments; Plaque, Amyloid; Sex Factors; Treatment Outcome | 2002 |
Nerve growth factor affects 11C-nicotine binding, blood flow, EEG, and verbal episodic memory in an Alzheimer patient (case report).
Topics: Aged; Alzheimer Disease; Butanols; Carbon Radioisotopes; Cerebral Cortex; Cerebrovascular Circulation; Cognition; Electroencephalography; Female; Humans; Injections, Intraventricular; Memory; Nerve Growth Factors; Neurosurgical Procedures; Nicotine; Temporal Lobe; Tomography, Emission-Computed | 1992 |
Effects of nicotine on spatial memory deficits in rats with septal lesions.
Topics: Alzheimer Disease; Animals; Discrimination Learning; Male; Memory Disorders; Nicotine; Rats; Septum Pellucidum; Spatial Behavior | 1992 |
Nicotine receptors in the brain of patients with Alzheimer's disease. Studies with 11C-nicotine and positron emission tomography.
Topics: Alzheimer Disease; Brain; Brain Chemistry; Carbon Radioisotopes; Humans; Nicotine; Receptors, Nicotinic; Tomography, Emission-Computed | 1991 |
Comparative alterations of nicotinic and muscarinic binding sites in Alzheimer's and Parkinson's diseases.
Topics: Aged; Alzheimer Disease; Binding Sites; Brain; Choline O-Acetyltransferase; Female; Humans; Male; Muscarine; Nicotine; Parkinson Disease | 1992 |
Relation between nicotine intake and Alzheimer's disease.
Topics: Adult; Alzheimer Disease; Case-Control Studies; Dementia; Female; Humans; Male; Middle Aged; Nicotine; Parkinson Disease; Smoking | 1991 |
A postmortem study of brain nicotinic receptors in Parkinson's and Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain Chemistry; Cognition Disorders; Humans; Kinetics; Nicotine; Parkinson Disease; Receptors, Nicotinic | 1991 |
Nicotine intake and Alzheimer's disease.
Topics: Alzheimer Disease; Humans; Nicotine; Risk Factors; Smoking | 1991 |
Studies on choline transport enhancement into fibroblasts from normals and Alzheimer's donors.
Topics: Aged; Alzheimer Disease; Biological Transport; Caffeine; Cell Line; Cells, Cultured; Choline; Dexamethasone; Fibroblasts; Humans; Male; Middle Aged; Nicotine; Reference Values | 1991 |
Neuroendocrine, physiologic, and behavioral responses following intravenous nicotine in nonsmoking healthy volunteers and in patients with Alzheimer's disease.
Topics: Adrenocorticotropic Hormone; Adult; Aged; Aged, 80 and over; Alzheimer Disease; Behavior; Dose-Response Relationship, Drug; Female; Humans; Hydrocortisone; Male; Middle Aged; Neurosecretory Systems; Nicotine; Prolactin; Psychiatric Status Rating Scales; Radioimmunoassay | 1990 |
Nicotinic acetylcholine receptor subtypes in human frontal cortex: changes in Alzheimer's disease.
Topics: Acetylcholine; Adult; Aged; Aged, 80 and over; alpha7 Nicotinic Acetylcholine Receptor; Alzheimer Disease; Animals; Binding Sites; Bungarotoxins; Electric Stimulation; Frontal Lobe; Humans; Male; Middle Aged; Nicotine; Rats; Rats, Inbred Strains; Receptors, Cholinergic; Receptors, Nicotinic | 1990 |
Selective changes in sensitivity to cholinergic agonists and receptor changes elicited by continuous physostigmine infusion.
Topics: Acetylcholinesterase; Alzheimer Disease; Analysis of Variance; Animals; Body Temperature; Brain; Dose-Response Relationship, Drug; Female; Mice; Mice, Inbred C57BL; Nicotine; Parasympatholytics; Parasympathomimetics; Physostigmine; Receptors, Nicotinic | 1990 |
Decreased uptake and binding of 11C-nicotine in brain of Alzheimer patients as visualized by positron emission tomography.
Topics: Aged; Alzheimer Disease; Brain; Carbon Radioisotopes; Humans; Middle Aged; Nicotine; Stereoisomerism; Tomography, Emission-Computed | 1990 |
Nicotine and Alzheimer's disease.
Topics: Alzheimer Disease; Humans; Nicotine | 1990 |
The effects of nicotine on attention, information processing, and short-term memory in patients with dementia of the Alzheimer type.
Topics: Adult; Aged; Alzheimer Disease; Arousal; Attention; Dose-Response Relationship, Drug; Female; Form Perception; Humans; Male; Memory, Short-Term; Nicotine; Pattern Recognition, Visual; Psychomotor Performance | 1989 |
Nicotine and dementia.
Topics: Alzheimer Disease; Humans; Memory; Nicotine; Receptors, Nicotinic; Smoking | 1989 |
Nicotinic binding sites in cerebral cortex and hippocampus in Alzheimer's dementia.
Topics: Acetylcholine; Alzheimer Disease; Cerebral Cortex; Cohort Studies; Female; Hippocampus; Humans; Male; Nicotine; Radioligand Assay; Receptors, Nicotinic | 1989 |
Alzheimer's disease. Arresting memory decline.
Topics: Alzheimer Disease; Animals; Carbolines; Cholinesterase Inhibitors; Humans; Memory Disorders; Nicotine; Piperidines; Rats; Receptors, Cholinergic; Receptors, GABA-A; Receptors, Nicotinic; Thiazoles | 1988 |
Nicotinic receptor abnormalities in Alzheimer's and Parkinson's diseases.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Alzheimer Disease; Dementia; Hippocampus; Humans; Huntington Disease; Middle Aged; Nicotine; Parkinson Disease; Receptors, Nicotinic; Thalamus | 1987 |
Change in nicotinic receptor subtypes in temporal cortex of Alzheimer brains.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Female; Humans; Male; Nicotine; Receptors, Nicotinic; Temporal Lobe | 1988 |
Reductions in acetylcholine and nicotine binding in several degenerative diseases.
Topics: Acetylcholine; Aged; Alzheimer Disease; Cerebral Cortex; Choline O-Acetyltransferase; Humans; Nicotine; Parkinson Disease; Receptors, Nicotinic; Supranuclear Palsy, Progressive | 1988 |
Nicotinic acetylcholine binding sites in Alzheimer's disease.
Topics: Acetylcholine; Aged; Alzheimer Disease; Cerebral Cortex; Choline O-Acetyltransferase; Humans; Nicotine; Receptors, Nicotinic | 1986 |
Characterization of L-[3H]nicotine binding in human cerebral cortex: comparison between Alzheimer's disease and the normal.
Topics: Adult; Aged; Aged, 80 and over; Aging; Alzheimer Disease; Animals; Carbachol; Cerebral Cortex; Choline O-Acetyltransferase; Humans; Middle Aged; Nicotine; Postmortem Changes; Rats; Receptors, Nicotinic | 1986 |
Intravenous nicotine in a patient with Alzheimer's disease.
Topics: Alzheimer Disease; Anxiety Disorders; Dose-Response Relationship, Drug; Humans; Infusions, Intravenous; Male; Middle Aged; Nicotine; Panic | 1986 |